0001144204-18-059990.txt : 20181114 0001144204-18-059990.hdr.sgml : 20181114 20181114163733 ACCESSION NUMBER: 0001144204-18-059990 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 43 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181114 DATE AS OF CHANGE: 20181114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CENTRAL INDEX KEY: 0001187953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870622284 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53500 FILM NUMBER: 181184554 BUSINESS ADDRESS: STREET 1: 2017 W PEORIA AVENUE CITY: PHOENIX STATE: AZ ZIP: 85029 BUSINESS PHONE: (602) 680-7439 MAIL ADDRESS: STREET 1: 2017 W PEORIA AVENUE CITY: PHOENIX STATE: AZ ZIP: 85029 FORMER COMPANY: FORMER CONFORMED NAME: JOLLEY MARKETING INC DATE OF NAME CHANGE: 20020910 10-Q 1 tv506610_10q.htm FORM 10-Q

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

 

  x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

    For the quarterly period ended September 30, 2018

  

Or

 

  ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

  

    For the transition period from ___________ to ___________

 

Commission File Number: 000-53500

 

Creative Medical Technology Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   87-0622284
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
2017 W Peoria Avenue, Phoenix, AZ   85029
(Address of principal executive offices)   (Zip Code)

 

(833) 336-7636

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports).

Yes x No ¨

 

Indicate by check mark whether the registrant has been subject to such filing requirements for the past 90 days.

Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer x Smaller reporting company x
    Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ¨ No x

 

The number of shares outstanding of the registrant’s common stock on November 14, 2018, was 830,514,426.

 

 

 

 

 

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30, 2018   December 31, 2017 
    (Unaudited)      
ASSETS          
CURRENT ASSETS          
Cash  $172,832   $13,697 
Accounts receivable   14,000    4,801 
Total Current Assets   186,832    18,498 
           
OTHER ASSETS          
Licenses, net of amortization   168,791    184,649 
TOTAL ASSETS  $355,623   $203,147 
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
           
CURRENT LIABILITIES          
Accounts payable  $242,843   $237,566 
Accrued expenses   29,640    23,140 
Management fee payable - related party   269,050    352,750 
Convertible notes payable, net of discount of $773,641 and $192,291, respectively   214,109    251,748 
Notes payable, net of discount of $0 and $0, respectively   125,000    125,000 
Notes payable - related party - current   -    125,000 
Advances from related party   10,800    10,800 
Derivative liabilities   6,818,117    1,309,190 
Total Current Liabilities   7,709,559    2,435,194 
           
LONG TERM LIABILITIES          
Convertible notes payable, net of discount of $0 and $54,085, respectively   -    915 
Accrued expenses, net of current portion   -    3,211 
TOTAL LIABILITIES   7,709,559    2,439,320 
           
Commitments and contingencies          
           
STOCKHOLDERS' DEFICIT          
Preferred stock, $0.001 par value, 7,000,000 shares authorized, no shares issued and outstanding at September 30, 2018 and December 31, 2017   -    - 
Series A preferred stock, $0.001 par value, 3,000,000 authorized, 3,000,000 shares issued and outstanding at September 30, 2018 and December 31, 2017   3,000    - 
Common stock, $0.001 par value, 3,000,000,000 shares authorized; 784,794,117 and 115,399,226 issued and 784,194,117 and 114,799,226 outstanding at September 30, 2018 and December 31, 2017, respectively   784,196    114,800 
Additional paid-in capital   10,874,552    1,074,707 
Accumulated deficit   (19,015,684)   (3,425,680)
TOTAL STOCKHOLDERS' DEFICIT   (7,353,936)   (2,236,173)
           
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT  $355,623   $203,147 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 2 

 

 

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

 

  

For the Three

Months Ended

September 30,
2018

  

For the Three

Months Ended

September 30,
2017

  

For the Nine
Months Ended
September 30,
2018

  

For the Nine
Months Ended
September 30,
2017

 
                 
Revenues  $52,400   $-   $66,800   $- 
                     
Cost of revenues   36,395    -    41,323    - 
                     
Gross profit   16,005    -    25,477    - 
                     
OPERATING EXPENSES                    
Research and development   2,884    87,728    10,284    172,748 
General and administrative, including stock-based compensation of $0, $1,689, $1,877 and $144,112, respectively   282,670    201,985    793,216    748,379 
Amortization of patent costs   5,286    5,286    15,858    10,709 
TOTAL EXPENSES   290,840    294,999    819,358    931,836 
                     
Operating loss   (274,835)   (294,999)   (793,881)   (931,836)
                     
OTHER INCOME/(EXPENSE)                    
Interest expense   (377,038)   (129,778)   (981,341)   (195,523)
Gain on extinguishment of convertible notes   -    -    496,645    - 
Change in fair value of derivatives liabilities   (919,147)   372,595    (14,311,427)   (54,530)
Total other expense   (1,296,185)   242,817    (14,796,123)   (250,053)
                     
OPERATING LOSS   (1,571,020)   (52,182)   (15,590,004)   (1,181,889)
                     
NET LOSS  $(1,571,020)  $(52,182)  $(15,590,004)  $(1,181,889)
                     
BASIC AND DILUTED LOSS PER SHARE  $(0.00)  $(0.00)  $(0.03)  $(0.01)
                     
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED   739,239,617    106,313,750    519,120,610    105,885,362 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 3 

 

 

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

  

For the Nine
Months Ended
September 30,
2018

  

For the Nine
Months Ended
September 30,
2017

 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(15,590,004)  $(1,181,889)
Adjustments to reconcile net loss to net cash from operating activities:          
Stock based compensation   1,877    144,112 
Amortization   15,858    10,709 
Amortization of debt discounts   878,349    173,578 
Increase in principal balance due to penalty provision   12,500    - 
Change in fair value of derivatives liabilities   14,311,427    54,530 
Gain on extinguishment of convertible notes payable   (496,645)   - 
Changes in assets and liabilities:          
Accounts receivable   (9,199)   - 
Accounts payable   5,765    90,713 
Accrued expenses   47,133    10,845 
Management fee payable   66,300    (69,500)
Net cash used in operating activities   (756,639)   (766,902)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from notes payable   -    90,000 
Payments on convertible notes payable   (405,294)   - 
Prepayment premiums paid on convertible notes payable   (57,004)   - 
Proceeds from convertible notes payable   1,378,072    376,250 
Proceeds from sale of common stock   -    100,000 
Net cash provided from financing activities   915,774    566,250 
           
NET INCREASE (DECREASE) IN CASH   159,135    (200,652)
BEGINNING CASH BALANCE   13,697    221,868 
ENDING CASH BALANCE  $172,832   $21,216 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash payments for interest  $6,712   $11,100 
Cash payments for income taxes  $-   $- 
           
NON-CASH FINANCING ACTIVITIES:          
Fair value of warrants issued in private placement  $-   $5,546 
Purchase of patents with amounts due to related party  $-   $100,000 
Conversion of notes payable, accrued interest and derivative liabilities
 into common stock
  $10,319,680   $- 
Conversion of management fees into preferred stock  $150,000   $- 
Beneficial conversion feature  $114,000   $- 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 4 

 

 

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

 

Introductory Comment

 

Unless otherwise indicated, any reference to “our company”, “we”, “us”, or “our” refers to Creative Medical Technology Holdings, Inc., and as applicable to its wholly owned subsidiary, Creative Medical Technologies, Inc., a Nevada corporation (“CMT”).

 

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization  -  Creative Medical Technology Holdings, Inc., is considered to be a commercial stage company, following the commencement of sales of stem cell separation equipment and disposable kits used in our Caverstem procedure to treat ED in the fourth quarter of 2017. Our fiscal year end is December 31st. We have acquired the licensing rights for our Amniostem amniotic-based stem cell, purchased the patent for our ED and lower back pain treatments, and filed patent applications for our neurological treatments.

 

Use of Estimates – The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2018 and for the three and nine month periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. The operations for the three and nine month periods ended September 30, 2018, are not necessarily indicative of the operating results for the full year.

 

Going Concern – The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, during the nine month period ended September 30, 2018, the Company incurred a net loss of $15,590,004 had negative cash flows from operating activities, had a working capital deficit of $7,522,727 and had minimal revenue-generating activities. These factors raise substantial doubt about the ability of the Company to continue as a going concern. In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of equity securities. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Revenue - The Company recognizes revenue as it is earned as defined by U.S. GAAP. We have adopted the new revenue recognition standard ASC 606 that went into effect on January 1, 2018 and determined there was no material impact to the Company’s financial statements. All revenues reported in 2018 and beyond will reflect those standards.

 

Fair Value of Financial Instruments   - The Company’s financial instruments consist of cash and cash equivalents, convertible notes, and payables.  The carrying amount of cash and cash equivalents and payables approximates fair value because of the short-term nature of these items.

 

When determining fair value, whenever possible the Company uses observable market data, and relies on unobservable inputs only when observable market data is not available. As of September 30, 2018 and December 31, 2017, the Company didn’t have any Level 1 or 2 financial instruments. The table below reflects the results of our Level 3 fair value calculations:

 

   Notes   Warrants   Total 
             
Derivative liability at December 31, 2017  $1,060,315   $248,875   $1,309,190 
Addition of new conversion option derivatives   2,839,915    365,268    3,205,183 
Conversion of note derivatives   (4,739,284)   (4,597,397)   (9,336,681)
Change in fair value   1,948,816    9,691,609    11,640,425 
Derivative liability at September 30, 2018  $1,109,762   $5,708,355   $6,818,117 

 

 5 

 

 

Basic and Diluted Loss Per Share – The Company follows Financial Accounting Standards Board (“FASB”) ASC 260 Earnings per Share to account for earnings per share. Basic earnings per share (“EPS”) calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. During the three and nine month periods ended September 30, 2018, the Company had 500,000 options and 255,771,846 warrants to purchase common stock outstanding. During the three and nine month periods ended September 30, 2017, the Company had 500,000 options and 966,667 warrants to purchase common stock outstanding. In addition, the Company has various convertible notes payable which at September 30, 2018 are convertible into approximately 73,750,820 shares of common stock. The effects of the dilutive securities were anti-dilutive due to net loss during the three and nine month periods ended September 30, 2018 and 2017.

 

Recent Accounting Pronouncements – In July 2017, the FASB issued ASU No. 2017-11, “Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815),” which addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.

 

The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements other than disclosed above.

 

NOTE 2 – LICENSING AGREEMENTS

 

ED Patent – The Company acquired a patent from CMH. Amortization expense of $2,493 and $7,479 were recorded for the three month and nine months periods ended September 30, 2018, respectively. As of September 30, 2018, the carrying value of the patent was $73,397. The Company expects to amortize approximately $9,972 annually through 2026 related to the patent costs.

 

Male Infertility License Agreement - The Company has acquired a royalty license from Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (“ LABIOMED ”) granting the exclusive license to the products and services of a LABIOMED patent.

 

The Company is subject to a 6% royalty payment to LABIOMED on net sales of any products under this license and 25% on any non-royalty sublicense income. Commencing in 2019, and each subsequent year thereafter, the Company is required to pay to LABIOMED annual maintenance royalties of $20,000, unless during the prior one-year period the Company paid $50,000 or more in actual royalty payments. Finally, the Company agreed to pay LABIOMED certain milestone payments upon achieving the milestones set forth in the agreement. As of September 30, 2018, no amounts are currently due to LABIOMED.

 

Multipotent Amniotic Fetal Stem Cells License Agreement - In August 2016, CMT entered into a License Agreement with a University. This license agreement grants to CMT the exclusive right to all products derived from a patent for use of multipotent amniotic fetal stem cells composition of matter throughout the world during the period ending on the expiration date of the longest-lived patent rights under the patent. CMT paid the University an initial license fee within 30 days of entering into the agreement. CMT is also required to pay annual license maintenance fees on each anniversary date of the agreement, which maintenance fees would be credited toward any earned royalties for any given period. The License Agreement provides for payment of various milestone payments and earned royalties on the net sales of licensed products by CMT or any sub licensee. CMT is also required to reimburse the University for any future costs associated with maintaining the patent. CMT may terminate the license agreement for any reason upon 90 days’ written notice and the University may terminate the agreement in the event CMT fails to meet its obligations set forth therein, unless the breach is cured within 30 days of the notice from the University specifying the breach. CMT is also obligated to indemnify the University against claims arising due to the exercise of the license by CMT or any sub licensee. As of September 30, 2018, no amounts are currently due to the University.

 

The Company estimates that the patent expires in February 2026 and has elected to amortize the patent through the period of expiration on a straight line basis. Amortization expense of $293 and $879 were recorded for the three and nine month periods ended September 30, 2018, respectively. As of September 30, 2018, the carrying value of the patent was $7,894. The Company expects to amortize approximately $1,172 annually through 2026 related to the patent costs.

 

 6 

 

 

Lower Back Patent – The Company, through a newly created subsidiary of CMT, StemSpine, LLC, acquired a patent from CMH, a related company, on May 17, 2017, for $100,000, payable in cash or stock. The patent expires on May 19, 2027 and the Company has elected to amortize the patent over a ten-year period on a straight line basis. Amortization expense of $2,500 and $7,500 were recorded for the three and nine month periods ended September 30, 2018, respectively. As of September 30, 2018, the carrying value of the patent was $87,500. The company expects to amortize approximately $10,000 annually through 2027 related to the patent costs.

 

For a period of five years from the date of the first sale of any product derived from the patent, StemSpine is required to make royalty payments of 5% from gross sales of products. StemSpine has also agreed to pay royalties of 50% of sale price or ongoing payments from third parties for licenses granted under the patent to third parties. In addition, StemSpine has agreed to make progress payments under the patent purchase agreement determined by whether the technology represented by the patent is tested by use of autologous cells or allogenic cells. In the case of pursuit of the technology using autologous cells, StemSpine has agreed to pay CMH $100,000 upon the signing of an agreement with a university for the initiation of an IRB clinical trial and $200,000 upon completion of the clinical trial. In the event StemSpine determines to pursue the technology using allogenic cells, StemSpine has agreed to pay CMH $100,000 upon the filing for IND with the FDA; $200,000 upon the dosing of the first patient in Phase 1-2 clinical trial; and $400,000 upon the dosing of the first patient in Phase 3 clinical trial. In each case StemSpine has the option to make these payments in cash or in shares of the Company’s common stock at a discount to the market price of the stock at the time of the transaction. The parties to the patent purchase agreement have agreed that in no event will the aggregate royalty payments under the agreement exceed $2,500,000.

 

NOTE 3 – RELATED PARTY TRANSACTIONS

 

The Company has incurred a monetary obligation to a related corporation to reimburse the cost of services provided to the Company (management and consulting) through September 30, 2018. Each of the Company’s executive officers is employed by the parent company, CMH, and will continue to receive his or her salary or compensation from CMH. The Company has an agreement with CMH which obligates the Company to reimburse CMH $35,000 per month for such services beginning January 2016. The compensation paid by CMH will include an allocation of services performed for CMH and for the Company. The amounts are presented as a “management fee payable - related party” on the accompanying unaudited condensed consolidated balance sheets. The liability is non-interest bearing, unsecured, and will be due upon the Company successfully raising at least $1,000,000 through the sale of equity. As of September 30, 2018, amounts due to CMH under the arrangement were $269,050.

 

On November 17, 2017, the Company entered into a Management Reimbursement Agreement dated November 17, 2017, with Creative Medical Technologies, Inc. (“ CMT ”), the wholly owned subsidiary of the Company, and with Creative Medical Health, Inc., the parent of the Company (“ CMH ”). The Agreement memorializes the arrangement between the parties whereby the Company has, since January 1, 2016, reimbursed CMH $35,000 per month for the services of management and consultants employed by CMH and performing services for the Company and CMT. At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days’ prior written notice.

 

On January 12, 2018, the Company entered into a Debt Settlement Agreement with Creative Medical Health, Inc., the parent of the Company, to exchange $150,000 in management fees owed to Creative Medical Health, Inc. in exchange for 3,000,000 shares of Series A Preferred Stock. In turn, Creative Medical Health, Inc. entered into a Debt Settlement Agreement with Timothy Warbington, our CEO, Chairman, and principal shareholder to transfer the 3,000,000 shares of Series A Preferred Stock in exchange for $150,000 of unpaid compensation owed to Mr. Warbington.

 

During 2016, the Company entered into three note payable agreements with CMH in which the proceeds were used in operations. The notes payable were dated February 2, 2016, May 1, 2016 and May 18, 2016 and resulted in borrowings of $50,000, $50,000 and $25,000, respectively. Notes payable of $50,000 mature on April 30, 2018, $50,000 on July 31, 2018 and $25,000 on May 18, 2018. On May 4, 2017, CMT and CMH entered into a Note Extension and Limited Waiver Agreement whereby the parties extended the maturity date of the 8% Promissory Note dated February 2, 2016, in the principal amount of $50,000, from April 30, 2017, to April 30, 2018, and CMH waived the nonpayment of the Note by CMT on the original maturity date. On extension, CMT paid to CMH accrued interest related to the extended note of $4,050. On July 31, 2017, CMT and CMH entered into a Note Extension and Limited Waiver Agreement whereby the parties extended the maturity date of the 8% Promissory Note dated May 1, 2016, in the principal amount of $50,000, from July 31, 2017, to July 31, 2018, and CMH waived the nonpayment of the Note by CMT on the original maturity date. On extension, CMT paid to CMH accrued interest related to the extended note of $4,050. The notes incur interest at 8% per annum on the outstanding balance of the notes.

 

On April 11, 2018 CMH converted the total principal and accrued interest on all three notes into 9,855,307 shares of common stock.

 

See Note 2 for discussion of an additional related party transaction with CMH.

 

 7 

 

 

NOTE 4 – DEBT

 

$400,000 Convertible Debenture – Peak One – Note 5

 

On May 2, 2017, the Company entered into a convertible debenture agreement with a third party for an aggregate principal amount of up to $400,000, for which up to $360,000 in proceeds is to be received. On May 2, 2017, the Company received the first tranche of proceeds of $85,000 for which the Company issued a convertible debenture in the face amount of $100,000. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $54,085 to interest expense respectively. As of September 30, 2018, a discount of $0 remained. During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal into 0 shares of common stock and $54,200 of principal into 23,485,183 shares of common stock respectively. On March 23, 2018, the Company paid the lender $1,000 to extinguish the remaining principal balance. As of September 30, 2018 the Company had fulfilled all the obligations of the debenture.

 

$115,000 Convertible Note – Auctus – Note 6

 

On April 10, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $115,000, for which $103,250 in proceeds were received on May 5, 2017. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of January 10, 2018. The note holder has notified the company they do not consider the note in default and their intent is to continue converting the remaining principal and accrued interest into common shares. During the three and nine month periods ended September 30, 2018, the Company amortized $0 and $4,600 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature and the warrants as derivative liabilities, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. During the three and nine month periods ended September 30, 2018, the lender did not convert any principal, interest and fees into common shares and converted $134,127 of principal, interest and fees into 145,929,641 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.

 

$55,000 Convertible Note – Global – Note 7

 

On April 24, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $55,000, for which $47,500 in proceeds were received on May 8, 2017. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of April 24, 2018. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $17,863 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature and the warrants as derivative liabilities, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. During the three and nine month periods ended September 30, 2018, the lender did not convert any principal, interest and fees into common shares and converted $47,613 of principal, interest and fees into 31,442,665 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.

 

$50,000 Secured Convertible Note – WBRE – Note 8

 

On June 26, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $50,000, for which $50,000 in proceeds were received on September 26, 2017. Under the terms of the agreement, the convertible note incurs interest at 12% per annum and matured on December 26, 2017. The convertible note has since been retired through a debt exchange agreement with a third party dated March 8, 2018, see "$60,000 Convertible Note" below.

 

$50,000 Convertible Note – Crown Bridge – Note 9

 

On July 19, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $50,000, for which $43,000 in proceeds were received on July 25, 2017. Under the terms of the agreement, the convertible note incurs interest at 5% per annum and has a maturity date of July 19, 2018. During the three and nine month ended September 30, 2018 the Company amortized $0 and $27,397 respectively to interest expense. As of September 30, 2018, a discount of $0 remained.

 

During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $54,697 of principal, interest and fees into 56,453,381 common shares respectively. As of September 30, 2018 there were 333,470,447 common shares reserved with our transfer agent. As of September 30, 2018 the Company had fulfilled all the obligations of the note.

 

 8 

 

 

$30,000 Convertible Note – Global – Note 14

 

On January 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $30,000, for which 12,500,000 outstanding warrants from the convertible note dated April 24, 2017 were extinguished. The difference between the convertible note, the conversion feature and the value of the warrants was recorded as a derivative loss. No proceeds were received in conjunction with this note. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of January 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of up to 0 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

The Company has the option to redeem the convertible notes at any time within 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.

 

During the three and nine month periods ended September 30, 2018, the lender converted $5,000 of principal, interest and fees into 816,994 common shares and $32,744 of principal, interest and fees into 5,350,345 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.

 

$44,000 Convertible Note – Adar Bays – Note 15

 

On January 17, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $44,000, for which $19,000 in proceeds were received on January 23, 2018 and $19,000 in proceeds were received on February 26, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of January 17, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing the on issuance discount of $4,000, legal fees of $2,000 and the remaining discount of $34,324 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $40,324 to interest expense using the straight-line method over the term of the loan. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $40,324 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

There is no option for the Company to redeem the convertible note prior to maturity.

 

 9 

 

 

During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $44,000 of principal, interest and fees into 27,518,485 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.

 

In connection with the original agreement, the holder had the option to fund three additional $44,000 back end convertible notes. On July 16, 2018, the holder exercised this option and entered into three separate $44,000 convertible notes totaling $132,000. For which the Company received a total of $114,000 in net proceeds. Under the terms of the agreements, the convertible notes incurred interest at 10% per annum and has a maturity date of January 17, 2019. The convertible note are convertible upon issuance at a fixed price of $0.025 per share. The Company is amortizing the on issuance discount of $18,000 and the remaining discount of $114,000 due to the recording of a beneficiation conversion feature. In July and August 2018, the convertible notes were converted into 5,280,000 shares of common stock. The Company amortized the entire discount of $132,000 to interest expense during the three and nine months ended September 30, 2018. As of September 30, 2018, a discount of $0 remained.

 

$12,500 Convertible Note – Global – Note 16

 

On January 22, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $12,500, in exchange for the release of reserved shares to the Company. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of January 22, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

The Company has the option to redeem the convertible note within 180 days from the date of issuance at 120% of the principal and interest. After 180 days the right of prepayment expires.

 

During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $12,925 of principal, interest and fees into 2,111,873 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.

 

$53,000 Convertible Note – PowerUp – Loan 17

 

On February 15, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $53,000, for which $50,000 in proceeds were received on February 22, 2018 . Under the terms of the agreement, the convertible note incurs interest at 12% per annum and has a maturity date of February 15, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 61% of the average of the two lowest traded prices of the Company’s common stock during the previous 15 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing the on issuance discount of $3,000 and the remaining discount of $50,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $53,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $0 and $53,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of up to 0 being reserved if and when the lender issues a request to our transfer agent.

 

 10 

 

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 22%.

 

The Company has the option to redeem the convertible notes within 90 days from the date of issuance at 115% of the principal and interest; between 91 and to 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.

 

On April 26, 2018 the Company retired the note with a payment of $82,084 to the note holder. A derivative liability gain of $279,795 was recorded to reflect the retirement of the derivative liability.

 

$27,500 Convertible Note – Global – Note 18

 

On March 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $27,500, for which proceeds of $23,500 were received on March 9, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is amortizing the discount of $27,500 due to on issuance discount of $4,000 and the recording of a derivative liability as discussed in Note 5. The Company is amortizing the discount of $27,500 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $0 and $27,500 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

The Company has the option to redeem the convertible notes within 30 days from the date of issuance at 115% of the principal and interest; between 31 and to 60 days from the date of issuance at 120% of the principal and interest; between 61 and to 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 120 days from the date of issuance at 130% of the principal and interest; between 121 and to 150 days from the date of issuance at 135% of the principal and interest; between 151 and 180 days from issuance at 140% of principal and interest; and after 180 days the right of prepayment expires.

 

During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $28,344 of principal, interest and fees into 4,631,346 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.

 

$60,000 Convertible Note – Global – WBRE Exchange – Note 19

 

March 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $60,000, in exchange for the extinguishment of the outstanding principal due on the convertible note dated September 26, 2017, see disclosure above for "$50,000 Secured Convertible Note". No proceeds were received in conjunction with the exchange of this convertible note. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. At no additional cost, we issued to the note holder 30,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.

 

 11 

 

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.

 

At the date of the agreement, the Company determined that the transactions qualified for extinguishment accounting whereby the transaction was accounted for at fair market value with the excess value between the fair value of the old note and new note was accounted for as an extinguishment loss of $154,284.

 

During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $60,147 of principal, interest and fees into 45,665,203 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.

 

$115,000 Convertible Note – Auctus – Note 20

 

On March 13, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $115,000, for which $97,250 in proceeds were received on March 19, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of December 13, 2018. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the average of the two lowest traded prices of the Company’s common stock during the previous 25 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to six times the number of common shares the convertible note is convertible into. The Company is amortizing the original issuance discount of $15,000 legal fees of $2,750 and the remaining discount of $97,250 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $115,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month periods ended September 30, 2018 the Company amortized $69,418 and $115,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 34,737,400 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 125% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

The Company has the option to redeem the convertible notes within 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 180 days from the date of issuance at 140% of the principal and interest; and after 180 days the right of prepayment expires.

 

During the three and nine month periods ended September 30, 2018, the lender converted $43,769 of principal, interest and fees into 34,737,400 common shares. On August 8, 2018, the Company retired the note and accrued interest with a payment of $106,312 to the note holder, which included a prepayment fee of $30,128 recorded within interest expense.

 

$48,000 Convertible Note – GS – Note 21

 

On March 15, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $48,000, for which $45,600 in proceeds were received on March 20, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 15, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 63% of the average of the two lowest traded prices of the Company’s common stock during the previous 12 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to six times the number of common shares the convertible note is convertible into. The Company is amortizing legal fees of $2,400 and the remaining discount of $45,600 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $48,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $0 and $48,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.

 

 12 

 

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

The Company has the option to redeem the convertible notes within 60 days from the date of issuance at 110% of the principal and interest; between 61 and to 120 days from the date of issuance at 124% of the principal and interest; between 121 days and to 180 days from the date of issuance at 138%; and after 180 days the right of prepayment expires.

 

On April 25, 2018 the Company retired the note with a payment of $60,000 to the note holder. A derivative liability gain of $209,076 was recorded to reflect the retirement of the derivative liability.

 

$110,000 Convertible Note – Morningview – Note 22

 

On April 3, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $95,000 in proceeds were received on April 3, 2018 . Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 29, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to five times the number of common shares the convertible note is convertible into. The Company is amortizing legal fees of $2,652 and the remaining discount of $107,348 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and nine months ended September 30, 2018 the Company amortized $27,726 and $54,247 to interest expense respectively. As of September 30, 2018, a discount of $55,753 remained. At no additional cost, we issued to the note holder 11,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 84,110,033 shares reserved with our transfer agent with a potential of 44,055,213 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 18%.

 

The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 140% of the principal and interest. After 180 days the right of prepayment expires.

 

$110,000 Convertible Note – Fourth Man – Note 23

 

On April 11, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $100,000 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity 12 months from the effective date of payment. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $10,000 and the remaining discount of $100,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $27,726 and $51,836 to interest expense respectively. As of September 30, 2018, a discount of $58,164 remained. At no additional cost, we issued to the note holder 11,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.

 

 13 

 

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 18,333,333 shares reserved with our transfer agent with a potential of 26,377,915 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 18%.

 

The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 140% of the principal and interest. After 180 days the right of prepayment expires.

 

$110,000 Convertible Note – Power Up – Note 24

 

On April 13, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $99,000 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 29, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $10,000, legal fees of $1,000 and the remaining discount of $99,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $27,726 and $51,836 to interest expense respectively. As of September 30, 2018, a discount of $58,164 remained.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 13,000,000 shares reserved with our transfer agent with a potential of 26,377,915 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 22%.

 

The Company has the option to redeem the convertible notes within 30 days from the date of issuance at 115% of the principal and interest; between 31 and to 60 days from the date of issuance at 120% of the principal and interest; between 61 and to 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 120 days from the date of issuance at 130% of the principal and interest; between 121 and to 150 days from the date of issuance at 135% of the principal and interest; between 151 and to 180 days from the date of issuance at 140% of the principal and interest; and after 180 days the right of prepayment expires.

 

$108,000 Convertible Note – Global – Note 25

 

On May 14, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $108,000, for which $94,960 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of May 14, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $8,000, legal fees of $5,040 and the remaining discount of $94,960 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $108,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $27,222 and $41,129 to interest expense. As of September 30, 2018, a discount of $66,871 remained. At no additional cost, we issued to the note holder 3,600,000 five-year warrants to purchase common stock at $0.025, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.

 

 14 

 

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 35,000,000 shares reserved with our transfer agent with a potential of 25,486,329 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

There is no option to pre-pay this note.

 

$108,000 Note – Global – Note 26

 

On June 27, 2018, the Company entered into a note agreement with a third party for an aggregate principal amount of $108,000, for which $100,000 in proceeds were received. Under the terms of the agreement, the note incurs interest at 8% per annum and has a maturity date of September 27, 2019. The Company is amortizing the on-issuance discount of $8,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $1,797 and $1,863 and to interest expense respectively. On September 20, 2018, this note was combined with other notes disclosed below, a portion of which was repaid with the remainder being rolled into Global - Note 28 disclosed below. As of September 30, 2018, a discount of $0 remained.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

$108,000 Note – Global – Note 27

 

On August 8, 2018, the Company entered into a note agreement with a third party for an aggregate principal amount of $108,000, for which $106,500 in proceeds were received. Under the terms of the agreement, the note incurs interest at 8% per annum and has a maturity date of August 8, 2019. The Company is amortizing the on-issuance discount of $1,500 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $177 to interest expense. On September 20, 2018, this note was combined with other notes disclosed immediately above and below, a portion of which was repaid with the remainder being rolled into Global - Note 28 disclosed below. As of September 30, 2018, a discount of $0 remained.

 

In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.

 

$183,250 Convertible Note – Global – Note 28

 

On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $100,000 in proceeds were received and remaining balances convertible notes disclosed above were rolled over. At the time of combination, the total carrying amount outstanding under the prior notes was $211,570. In connection, with the agreement, Global was paid $139,352, principal of $69,676 rolled into the new note and a gain of $2,542 was recorded within interest expense. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company’s stock at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574 and the remaining discount of $169,676 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.

 

 15 

 

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.

 

The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.

 

$183,250 Convertible Note – Morningview – Note 29

 

On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $169,676 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company’s stock at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574, legal fees of $8,363 and the remaining discount of $161,313 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.

 

The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.

 

$183,250 Convertible Note – Fourth Man – Note 29

 

On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $169,676 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company’s stock at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574, legal fees of $8,363 and the remaining discount of $161,313 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.

 

 16 

 

 

The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.

 

In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.

 

The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the Company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.

 

As of September 30, 2018, future loan maturities are as follows:

 

For the year ended December 31,    
     
2018   0 
2019   987,750 
Total  $987,750 

 

NOTE 5 – DERIVATIVE LIABILITIES

 

Derivative Liabilities

 

In connection with convertible notes payable, the Company records derivative liabilities for the conversion feature. In addition, the Company has warrants for which the exercise prices reset upon future events. These warrants are also considered to be derivative liabilities. The derivative liabilities are valued on the date the convertible note payable become convertible and revalued at each reporting period. The warrants are valued on the date of issuance and revalued at each reporting period. During the nine months ended September 30, 2018, the Company recorded initial derivative liabilities of $3,205,183 based upon the following Black-Scholes option pricing model average assumptions: an exercise price of $0.0009 to $0.0137 our stock price on the date of grant of $0.0029 to $0.0550, expected dividend yield of 0%, expected volatility of 86% to 214%, risk free interest rate of 2.03% to 2.80% and expected terms ranging from 1.0 to 5.0 years. Upon initial valuation, the derivative liability exceeded the face value certain of the convertible note payables by approximately $2,671,002, which was recorded as a day one loss on derivative liability.

 

On September 30, 2018, the derivative liabilities were revalued at $6,818,117 resulting in a loss of $919,147 related to the change in fair market value of the derivative liabilities during the three months ended September 30, 2018. The total loss related to the change in fair market value of the derivative liabilities during the nine months ended September 30, 2018 was $11,640,425. The derivative liabilities were revalued using the Black-Scholes option pricing model with the following average assumptions: an exercise price of $0.0008 to $0.0880, our stock price on the date of valuation ($0.0234), expected dividend yield of 0%, expected volatility of 95% to 214%, risk-free interest rates ranging from 2.63 - 2.80%, and an expected terms ranging from 0.5 to 4.9 years.

 

In connection with convertible notes converted and warrants exercised, as disclosed in Note 5, the Company reclassed derivative liabilities with a fair value of $9,336,681 to additional paid-in capital. The Company revalued the derivative liabilities at each conversion date recording the pro-rata portion of the derivative liability as compared to the portion of the convertible note converted to the pre-conversion carrying value to additional paid-in capital

 

Future Potential Dilution

 

Most of the Company’s convertible notes payable contain adjustable conversion terms with significant discounts to market. As of September 30, 2018 the Company’s convertible notes payable are potentially convertible into an aggregate of approximately 74 million shares of common stock. In addition, due to the variable conversion prices on some of the Company’s convertible notes, the number of common shares issuable is dependent upon the traded price of the Company’s common stock.

 

 17 

 

 

NOTE 6 – WARRANTS

 

The fair value of each warrant is estimated using the Black-Scholes valuation model. Assumptions used in calculating the fair value at September 30, 2018 were as follows:

 

    Weighted
Average
Inputs Used
 
       
Annual dividend yield   $ -  
Expected life (years)     3.8 to 4.9  
Risk-free interest rate     2.63 %
Expected volatility     91 %
Common stock price   $ 0.0234  

 

Since the expected life of the options was greater than the Company’s historical stock information available, the Public Company determined the expected volatility based on price fluctuations of comparable public companies.

 

The issuances, exercises and pricing re-sets during the nine months ended September 30, 2018 are as follows:

          

Outstanding at December 31, 2017     23,426,087  
Issuances     69,919,777  
Exercises     (223,803,769 )
Anti-Dilution/Modification     401,430,751  
Forfeitures/cancellations     (15,200,000 )
Outstanding at September 30, 2018     255,772,846  
Weighted Average Price at September 30, 2018   $ 0.0023  

 

NOTE 7 – SUBSEQUENT EVENTS

 

In accordance with ASC 855, management reviewed all material events through August 14, 2018, for these financial statements and there are no material subsequent events to report, except as follows:

 

Conversion Notice

 

From October 16, 2018 through October 22, 2018 we issued 11,967,158 shares of common stock for the conversion of $115,000 in convertible notes.

 

On October 18, 2018 we issued 9,297,576 shares of common stock to a lender whom exercised 10,000,000 warrants in a cashless exercise. 

 

On November 12, 2018 we issued 25,055,575 shares of common stock to a lender whom exercised 28,200,000 warrants in a cashless exercise.

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations analyzes the major elements of our balance sheets and statements of income. This section should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2017, and our interim financial statements and accompanying notes to these financial statements included in this report. All amounts are in U.S. dollars.

 

 18 

 

 

Forward-Looking Statement Notice

 

This quarterly report on Form 10-Q contains forward-looking statements about our expectations, beliefs or intentions regarding, among other things, our product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, we or our representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as “believe,” “expect,” “intend,” “plan,” “may,” “should” or “anticipate” or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by us with the SEC, press releases or oral statements made by or with the approval of one of our authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, those set forth in our most recent annual report referenced below.

 

This report identifies important factors which could cause our actual results to differ materially from those indicated by the forward-looking statements.

 

All forward-looking statements attributable to us or persons acting on our behalf speak only as of the date of this report and are expressly qualified in their entirety by the cautionary statements included in this report. We undertake no obligations to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. In evaluating forward-looking statements, you should consider these risks and uncertainties.

 

Overview

 

We are considered to be a commercial stage company, following the commencement of sales of stem cell separation equipment and disposable kits used in our Caverstem procedure to treat ED in the fourth quarter of 2017. Our fiscal year end is December 31st. We have acquired the licensing rights for our Amniostem amniotic-based stem cell, purchased the patent for our ED and lower back pain treatments, and filed patent applications for our neurological treatments.

 

During the first nine months of 2018, we issued $1,448,750 in convertible notes with net proceeds of $1,378,072 to accredited investors. In addition, we issued $12,500 in convertible notes for the release of reserved shares and a $60,000 convertible note in exchange for a $50,000 convertible note.

 

Plan of Operations

 

We commenced marketing stem cell concentration machines and disposable kits for the Caverstem ED treatment in the fourth quarter of 2017. For the next 12 months our plan of operations is to market our stem cell concentration machines and disposable kits, complete the UCLA/LABiomed clinical trial and partner with leading researchers on investigator-initiated trials to advance our neurological programs. We estimate the costs to complete the clinical trials will be approximately $300,000, excluding overhead and other costs associated with maintaining our company structure. As of September 30, 2018, we had approximately $173,000 cash on hand. With an estimated monthly cash burn rate of approximately $95,000 based on historic trends and anticipated future revenues and expenses, management anticipates sufficient cash on hand and committed funds to meet operating expenses and costs of the current operations through at least November 2018. Historically, we have met our cash flow requirements through the sale of equity securities or borrowed funds. We intend to fund our business through sales of stem cell centration machines and disposable kits along with continuing to seek investments to meet our cash flow requirements, including both operating expenses and the balance of funding required to fund our sales efforts and compete our ED clinical trial. The securities offered by us to potential investors have not been registered under the Securities Act of 1933, as amended (the “ Act ”), and may not be offered or sold in the U.S. absent registration or an applicable exemption from registration requirements. If we are unable to obtain further financing, we may seek alternative sources of funding or revise our business plan. We currently have no alternative sources for funding.

 

Results of Operations – For the Three Month Period Ended September 30, 2018 and 2017

 

Gross Revenue. We generated $52,400 gross revenue for the three month period ended September 30, 2018 in comparison with $0 for the comparable quarter a year ago.

 

Cost of Goods Sold. We generated $36,395 cost of goods sold for the three month period ended September 30, 2018 in comparison with $0 for the comparable quarter a year ago.

 

Gross Profit/(Loss). We generated $16,005 in gross profit for the three month period ended September 30, 2018 in comparison with $0 for the comparable quarter a year ago.

 

General and Administrative Expenses. General and administrative expenses for the three month period ended September 30, 2018, totaled $282,670, in comparison with $201,985, for the comparable quarter a year ago. The increase of $80,685, or 40% is primarily due to an increase of $47,759 in marketing and $32,272 in travel associated with commercializing the Caverstem procedure.

 

Research and Development Expenses. Research and development expenses for the three month period ended September 30, 2018, totaled $2,884 in comparison with $87,728, for the comparable quarter a year ago. The decrease of $84,844, or 97% is primarily due to a decrease of $77,644 in clinical research expenses associated with the erectile dysfunction trial and a reduction of $7,200 in laboratory expenses.

 

 19 

 

 

Other Income / Expense. Other expense for the three month period ended September 30, 2018, totaled $1,296,185 in comparison with other income of $242,817, for the comparable quarter a year ago. The increased expense of $1,539,002, or 634% is due to an increase of $247,260 in interest expense, an increased expense of $1,291,742 associated with the change in the fair value of derivative liabilities.

 

Net Loss. For the reasons stated above, our net loss for the three month period ended September 30, 2018 totaled $1,571,020 in comparison to $52,182, for the comparable quarter a year ago.

 

Results of Operations – For the Nine month Period Ended September 30, 2018 and 2017

 

Gross Revenue. We generated $66,800 gross revenue for the nine month period ended September 30, 2018 in comparison with $0 for the comparable quarter a year ago.

 

Cost of Goods Sold. We generated $41,323 cost of goods sold for the nine month period ended September 30, 2018 in comparison with $0 for the comparable quarter a year ago.

 

Gross Profit/(Loss). We generated $25,477 in gross profit for the nine month period ended September 30, 2018 in comparison with $0 for the comparable quarter a year ago.

 

General and Administrative Expenses. General and administrative expenses for the nine month period ended September 30, 2018, totaled $793,216, in comparison with $748,379, for the comparable period a year ago. The increase of $44,837, or 6% is primarily due to an increase of $110,170 in marketing and $72,557 in travel associated with the commercialization of the Caverstem procedure and an increase of $30,365 in business development expenses, offset by reductions of $142,235 in stock-based compensation, $22,836 in public company costs and $14,658 in legal fees.

 

Research and Development Expenses. Research and development expenses for the nine month period ended September 30, 2018, totaled $10,284 in comparison with $172,478 for the comparable period a year ago. The decrease of $162,464, or 94% is primarily due to a decrease of $142,240 in clinical research expenses associated with the erectile dysfunction trial as the trial nears completion and a reduction of $22,224 in laboratory expenses.

 

Other Income / Expense. Other expense for the nine month period ended September 30, 2018, totaled $14,796,123 in comparison with other expense of $250,053, for the comparable period a year ago. The increase of $14,546,070, or 5,817% is primarily due to an increase of $785,818 in interest expense, and a $14,256,897 expense increase associated with the change in the fair value of derivative liabilities, offset by a $496,645 gain on the extinguishment of convertible notes,

 

Net Loss. For the reasons stated above, our net loss for the nine month period ended September 30, 2018 totaled $15,590,004 in comparison to $1,181,899, for the comparable quarter a year ago.

 

Liquidity and Capital Resources

 

Our principal source of liquidity has been funds received from the sale of our common stock and issuance of notes including convertible notes. Our experience to-date indicates the lenders are most likely to convert the debt into equity prior to or in lieu of full payment at maturity. Going forward, our short-term funding needs are expected to be satisfied by funds to be loaned to us by third parties and revenues generated from our Caverstem ED procedure. Our long-term liquidity needs are expected to be satisfied from future offerings of our equity securities. It is possible that CMH may provide future financing for us. We do not have any arrangements, agreements, or sources for long-term funding.

 

Our only commitments for expenditures relate to the completion of the clinical study for the ED stem cell treatment and general and administrative costs, including reimbursements to our parent company for services performed by their executive officers on our behalf. During the next 12 months we also anticipate incurring expenses related to marketing activities for our ED treatment.

 

For the next 12 months our plan of operations is to market the stem cell separator and disposable kits associated with the Caverstem ED treatment and complete the UCLA/LABiomed clinical trial. We estimate the costs to complete the clinical trials will be approximately $300,000, excluding overhead and other costs associated with maintaining our company structure. We believe that our current cash on hand would meet our cash flow requirements for only a few more months. If we are unable to obtain further financing, we may seek alternative sources of funding or revise our business plan. We currently have no alternative sources for funding.

 

 20 

 

 

Our financial statements included with this report have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We have incurred substantial expenses and generated minimal revenues from operations during the periods covered by these financial statements. These factors raise substantial doubt about our ability to continue as a going concern. There is no assurance that we will be successful in meeting the continuing financial obligations of the company. Our financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Cash Flows

 

Net Cash used in Operating Activities. We used cash in our operating activities due to our losses from operations. Net cash used in operating activities was $756,639 for the nine month period ended September 30, 2018 in comparison to $766,902 for the comparable period a year ago, a decrease of $10,263 or 1%. The decrease in cash used in operations was primarily related to a $10,000 decrease in accounts receivable.

 

Net Cash used in Investing Activities. There was no cash used in investing activities in the nine month period ended September 30, 2018 and for the comparable period a year ago.

 

Net Cash From Financing Activities. In the nine month period ended September 30, 2018 we raised $1,378,072 through the issuance of convertible and non-convertible debt, expended $405,294 to retire convertible debt and paid $57,004 in prepayment premiums on the retired convertible notes. In the nine month period ended September 30, 2017, we raised $100,000 through the sale of common stock, $90,000 in proceeds from notes payable and $376,250 in proceeds from convertible notes. The increase in cash flows from financing activities were primarily related to our need to obtain additional capital due marketing and travel expenses associated with the commercialization of the Caverstem ED procedure, increases in capital markets marketing costs and increased legal and accounting fees associated with public company reporting and audit requirements.

 

Basis of Presentation / Going Concern

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.   As of September 30, 2018, the Company had $172,832 of available cash and a working capital deficit of $7,522,727.  For the nine month period ended September 30, 2018, the Company had $66,800 in revenue, $15,590,004 in operating loss and used net cash for operating activities of $756,639. These factors, among others, indicate that the Company may be unable to continue as a going concern for the next twelve months. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing as may be required, and ultimately to attain sufficient cash flow from operations to meet its obligations on a timely basis. Management is in the process of negotiating various financing plans including access to ongoing credit facilities and possible sale of capital stock either in private or in public offerings and believes these steps may generate sufficient cash flow for the Company to continue as a going concern. If the Company is unsuccessful in these efforts, it may be required to substantially curtail or terminate its operations.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our consolidated financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity capital expenditures or capital resources.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

As a smaller reporting company, we have elected not to provide the disclosure required by this item.

 

Item 4. Controls and Procedures

 

Evaluation of disclosure controls and procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13(a)-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report are effective in ensuring that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

 21 

 

 

Changes in internal control over financial reporting

 

There were no changes in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II – OTHER INFORMATION

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Convertible Notes/Debentures

 

During the three-month period ended September 30, 2018, we issued a promissory note in the face amount of $108,000 receiving proceeds of $106,500 and convertible promissory notes in the aggregate face amount of $681,750 to multiple lenders for which we received proceeds of $553,352. Of the proceeds received, $274,118 was used to pre-pay two notes dated June 27,2018 and August 8, 2018. In addition, $69,676 of princpial from the $108,000 note was rolled into the convertible promissory notes. The notes bear interest at rates ranging from 8% - 10% which would increase ranging from 24% in the event of default and have maturity dates ranging from January 2019 through September 2019. Notes in the amount of $549,750 are convertible at 65% of the lowest traded price of our common stock during 20 prior trading days preceding the conversion date. The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the Company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires. Notes in the amount of $144,000 were convertible at a fixed conversion price of $0.025 and included within the share issuances discussed above. There were no prepayments allowed on these notes.

 

In connection with the transactions above, during the three-month period ended September 30, 2018, we issued to the lenders an aggregate of warrants to purchase 3,742,854 shares of our Common Stock exercisable at $0.088 per share terminating five years from the issuance dates. The warrants include cashless exercise provisions.

 

The issuance of these securities was made pursuant to Rule 506(b) of Regulation D promulgated by the SEC under the Securities Act as a transaction not involving any public offering. No selling commissions or other remuneration were paid in connection with the issuance of these shares.

 

From July, 1 2018 through September 30, 2018, we issued an aggregate of 40,834,394 shares upon the conversions of outstanding notes and 66,228,985 shares upon the cashless exercise of outstanding warrants. These conversions were made pursuant to the exemption provided by Section 3(a)(9) of the Securities Act of 1933. As a result of these issuances, we had outstanding 784,794,117 shares of common stock as of September 30, 2018.

 

 Item 6. Exhibits

 

SEC Ref. No.   Title of Document
31.1   Rule 13a-14(a) Certification by Principal Executive Officer
31.2   Rule 13a-14(a) Certification by Principal Financial Officer
32.1   Section 1350 Certification of Principal Executive Officer
32.2   Section 1350 Certification of Principal Financial Officer
101.INS   XBRL Instance Document
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

 22 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Creative Medical Technology Holdings, Inc.
     
Date: November 14, 2018 By /s/ Timothy Warbington
    Timothy Warbington, Chief Executive Officer
    (Principal Executive Officer) 
     
Date: November 14, 2018 By /s/ Donald Dickerson
    Donald Dickerson, Chief Financial Officer
    (Principal Financial Officer)

 

 23 

 

EX-31.1 2 tv506610_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Timothy Warbington, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Creative Medical Technology Holdings, Inc. for the quarter ended September 30, 2018;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2018 By: /s/ Timothy Warbington
    Timothy Warbington
    Chief Executive Officer
    (Principal Executive Officer)

 

 

 

EX-31.2 3 tv506610_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Donald Dickerson, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Creative Medical Technology Holdings, Inc. for the quarter ended September 30, 2018;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2018 By: /s/ Donald Dickerson
    Donald Dickerson
    Chief Financial Officer
    (Principal Financial Officer)

 

 

 

EX-32.1 4 tv506610_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with this Quarterly Report of Creative Medical Technology Holdings, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Timothy Warbington, Chief Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.Such Quarterly Report on Form 10-Q for the period ended September 30, 2018, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in such Quarterly Report on Form 10-Q for the period ended September 30, 2018 fairly presents, in all material respects, the financial condition and results of operations of Creative Medical Technology Holdings, Inc.

 

Date: November 14, 2018 By: /s/ Timothy Warbington
    Timothy Warbington
    Chief Executive Officer
    (Principal Executive Officer)

 

 

 

EX-32.2 5 tv506610_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with this Quarterly Report of Creative Medical Technology Holdings, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Donald Dickerson, Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.Such Quarterly Report on Form 10-Q for the period ended September 30, 2018, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in such Quarterly Report on Form 10-Q for the period ended September 30, 2018, fairly presents, in all material respects, the financial condition and results of operations of Creative Medical Technology Holdings, Inc.

 

Date: November 14, 2018 By: /s/ Donald Dickerson
    Donald Dickerson
    Chief Financial Officer
    (Principal Financial Officer)

 

 

 

EX-101.INS 6 celz-20180930.xml XBRL INSTANCE DOCUMENT 0001187953 2018-01-01 2018-09-30 0001187953 2018-07-01 2018-09-30 0001187953 2017-07-01 2017-09-30 0001187953 2017-01-01 2017-09-30 0001187953 2018-09-30 0001187953 2017-12-31 0001187953 2018-11-14 0001187953 2017-11-01 2017-11-17 0001187953 2018-08-01 2018-08-31 0001187953 2018-08-01 2018-08-08 0001187953 2018-08-08 0001187953 2018-09-20 0001187953 2018-09-01 2018-09-30 0001187953 2018-09-01 2018-09-20 0001187953 2018-07-01 2018-07-16 0001187953 2018-04-01 2018-04-13 0001187953 2018-01-01 2018-01-17 0001187953 2018-01-17 0001187953 2018-04-03 0001187953 2016-12-31 0001187953 2017-09-30 0001187953 celz:NotesMember 2018-01-01 2018-09-30 0001187953 us-gaap:WarrantMember 2018-01-01 2018-09-30 0001187953 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0001187953 us-gaap:EmployeeStockOptionMember srt:MinimumMember 2018-01-01 2018-09-30 0001187953 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2018-01-01 2018-09-30 0001187953 celz:RevaluationMember 2018-01-01 2018-09-30 0001187953 srt:MinimumMember 2018-01-01 2018-09-30 0001187953 srt:MaximumMember 2018-01-01 2018-09-30 0001187953 srt:MinimumMember celz:RevaluationMember 2018-01-01 2018-09-30 0001187953 srt:MaximumMember celz:RevaluationMember 2018-01-01 2018-09-30 0001187953 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0001187953 celz:StemspineLlcMember us-gaap:PatentsMember 2018-01-01 2018-09-30 0001187953 celz:CreativeMedicalHealthIncMember us-gaap:PatentsMember 2018-01-01 2018-09-30 0001187953 celz:MultipotentAmnioticFetalStemCellsLicenseAgreementMember us-gaap:PatentsMember 2018-01-01 2018-09-30 0001187953 celz:CreativeMedicalHealthMember 2018-01-01 2018-09-30 0001187953 us-gaap:LicensingAgreementsMember 2018-01-01 2018-09-30 0001187953 us-gaap:PatentsMember 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt115000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt27500Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt60000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt44000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt400000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt55000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt12500Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleNoteAuctusMember 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt30000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleSecuredDebt50000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt110000FourthManMember 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt53000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt110000PowerupMember 2018-01-01 2018-09-30 0001187953 celz:ConvertibleNote108000Global2Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleNote183250GlobalMember 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt48000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt110000Member 2018-01-01 2018-09-30 0001187953 celz:ConvertibleNote108000GlobalMember 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt108000GlobalMember 2018-01-01 2018-09-30 0001187953 celz:ConvertibleDebt183250FourthManMember 2018-01-01 2018-09-30 0001187953 celz:ConvertibleNote183250MorningviewMember 2018-01-01 2018-09-30 0001187953 us-gaap:ConvertibleNotesPayableMember 2018-09-30 0001187953 us-gaap:NotesPayableOtherPayablesMember 2018-09-30 0001187953 us-gaap:SeriesAPreferredStockMember 2018-09-30 0001187953 celz:RevaluationMember 2018-09-30 0001187953 srt:MinimumMember celz:RevaluationMember 2018-09-30 0001187953 srt:MaximumMember celz:RevaluationMember 2018-09-30 0001187953 srt:MinimumMember 2018-09-30 0001187953 srt:MaximumMember 2018-09-30 0001187953 us-gaap:EmployeeStockOptionMember 2018-09-30 0001187953 celz:CreativeMedicalHealthMember 2018-09-30 0001187953 celz:StemspineLlcMember us-gaap:PatentsMember 2018-09-30 0001187953 us-gaap:LicensingAgreementsMember 2018-09-30 0001187953 us-gaap:PatentsMember 2018-09-30 0001187953 celz:SecuredConvertibleNote50000Member 2018-09-30 0001187953 celz:ConvertibleDebt108000GlobalMember 2018-09-30 0001187953 celz:ConvertibleSecuredDebt50000Member 2018-09-30 0001187953 celz:ConvertibleDebt110000Member 2018-09-30 0001187953 celz:ConvertibleDebt110000FourthManMember 2018-09-30 0001187953 celz:ConvertibleDebt44000Member 2018-09-30 0001187953 celz:ConvertibleDebt44000Member srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleNoteGlobalMember 2018-09-30 0001187953 celz:ConvertibleDebt48000Member 2018-09-30 0001187953 celz:ConvertibleDebt48000Member srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleDebt115000Member 2018-09-30 0001187953 celz:ConvertibleDebt115000Member srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleDebt53000Member 2018-09-30 0001187953 celz:ConvertibleDebt53000Member srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleNoteGlobalMember srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleDebt110000PowerupMember 2018-09-30 0001187953 celz:ConvertibleDebt108000GlobalMember srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleNote183250GlobalMember 2018-09-30 0001187953 celz:ConvertibleNote183250GlobalMember srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleNote183250MorningviewMember 2018-09-30 0001187953 celz:ConvertibleNote183250MorningviewMember srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleDebt183250FourthManMember 2018-09-30 0001187953 celz:ConvertibleDebt183250FourthManMember srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleDebt110000PowerupMember srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleDebt110000Member srt:MaximumMember 2018-09-30 0001187953 celz:ConvertibleDebt110000FourthManMember srt:MaximumMember 2018-09-30 0001187953 us-gaap:ConvertibleNotesPayableMember 2017-12-31 0001187953 us-gaap:NotesPayableOtherPayablesMember 2017-12-31 0001187953 us-gaap:SeriesAPreferredStockMember 2017-12-31 0001187953 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-09-30 0001187953 us-gaap:WarrantMember 2017-01-01 2017-09-30 0001187953 us-gaap:EmployeeStockOptionMember 2017-07-01 2017-09-30 0001187953 us-gaap:WarrantMember 2017-07-01 2017-09-30 0001187953 celz:RevaluationMember 2018-07-01 2018-09-30 0001187953 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0001187953 us-gaap:WarrantMember 2018-07-01 2018-09-30 0001187953 celz:CreativeMedicalHealthIncMember us-gaap:PatentsMember 2018-07-01 2018-09-30 0001187953 celz:MultipotentAmnioticFetalStemCellsLicenseAgreementMember us-gaap:PatentsMember 2018-07-01 2018-09-30 0001187953 celz:StemspineLlcMember us-gaap:PatentsMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleSecuredDebt50000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt44000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt12500Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt60000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt27500Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt400000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleNoteAuctusMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt30000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt110000PowerupMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt108000GlobalMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt110000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleNote183250GlobalMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleNote183250MorningviewMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt183250FourthManMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleNote108000GlobalMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt110000FourthManMember 2018-07-01 2018-09-30 0001187953 celz:ConvertibleNote108000Global2Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt53000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt48000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt115000Member 2018-07-01 2018-09-30 0001187953 celz:ConvertibleDebt55000Member 2018-07-01 2018-09-30 0001187953 celz:CreativeMedicalHealthMember celz:FebruaryNoteMember 2016-01-01 2016-12-31 0001187953 celz:CreativeMedicalHealthMember celz:MayNoteOneMember 2016-01-01 2016-12-31 0001187953 celz:CreativeMedicalHealthMember celz:MayNoteTwoMember 2016-01-01 2016-12-31 0001187953 celz:StemspineLlcMember us-gaap:PatentsMember 2017-05-03 2017-05-17 0001187953 celz:StemspineLlcMember 2017-05-03 2017-05-17 0001187953 celz:InitiationOfClinicalTrialMember 2017-05-03 2017-05-17 0001187953 celz:CompletionOfClinicalTrialMember 2017-05-03 2017-05-17 0001187953 celz:FilingForIndWithFdaMember 2017-05-03 2017-05-17 0001187953 celz:ClosingOfFirstPatientInPhase12ClinicalTrialMember 2017-05-03 2017-05-17 0001187953 celz:ClosingOfFirstPatientInPhase3ClinicalTrialMember 2017-05-03 2017-05-17 0001187953 srt:MaximumMember 2017-05-03 2017-05-17 0001187953 celz:CreativeMedicalHealthMember 2017-11-17 0001187953 celz:CreativeMedicalHealthMember us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-01-12 0001187953 us-gaap:SeriesAPreferredStockMember celz:TimothyWarbingtonMember 2018-01-01 2018-01-12 0001187953 celz:CreativeMedicalHealthMember celz:FebruaryNoteMember 2016-12-31 0001187953 celz:CreativeMedicalHealthMember celz:MayNoteOneMember 2016-12-31 0001187953 celz:CreativeMedicalHealthMember celz:MayNoteTwoMember 2016-12-31 0001187953 celz:CreativeMedicalHealthMember 2016-12-31 0001187953 celz:CreativeMedicalHealthMember celz:FebruaryNoteMember 2017-05-03 2017-05-04 0001187953 celz:CreativeMedicalHealthMember celz:FebruaryNoteMember 2017-05-04 0001187953 celz:CreativeMedicalHealthMember celz:MayNoteOneMember 2017-07-01 2017-07-31 0001187953 us-gaap:CommonStockMember 2018-04-01 2018-04-11 0001187953 celz:ConvertibleDebt110000FourthManMember 2018-04-01 2018-04-11 0001187953 celz:ConvertibleDebt400000Member 2017-04-16 2017-05-02 0001187953 celz:FirstTrancheMember celz:ConvertibleDebt400000Member 2017-04-16 2017-05-02 0001187953 celz:FirstTrancheMember celz:ConvertibleDebt400000Member 2017-05-02 0001187953 celz:ConvertibleDebt400000Member 2017-05-02 0001187953 celz:ConvertibleDebt115000Member 2017-04-02 2017-04-10 0001187953 celz:ConvertibleDebt115000Member 2017-04-10 0001187953 celz:ConvertibleDebt55000Member 2017-04-02 2017-04-24 0001187953 celz:ConvertibleDebt55000Member 2017-04-24 0001187953 celz:SecuredConvertibleNote50000Member 2017-06-02 2017-06-26 0001187953 celz:SecuredConvertibleNote50000Member 2017-06-26 0001187953 celz:ConvertibleNote50000OneMember 2017-06-26 0001187953 celz:ConvertibleSecuredDebt50000Member 2017-07-01 2017-07-19 0001187953 celz:ConvertibleSecuredDebt50000Member 2017-07-01 2017-07-25 0001187953 celz:ConvertibleSecuredDebt50000Member 2017-07-19 0001187953 celz:ConvertibleDebt30000Member 2018-01-01 2018-01-09 0001187953 celz:ConvertibleDebt30000Member 2018-01-09 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodafter180DaysMember 2018-01-09 0001187953 celz:ConvertibleDebt44000Member 2018-01-01 2018-01-17 0001187953 celz:ConvertibleDebt44000Member srt:MaximumMember 2018-01-01 2018-01-17 0001187953 celz:ConvertibleDebt44000Member 2018-01-02 2018-01-23 0001187953 celz:ConvertibleDebt44000Member 2018-01-17 0001187953 celz:ConvertibleDebt12500Member 2018-01-01 2018-01-22 0001187953 celz:ConvertibleDebt12500Member 2018-01-22 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodafter180DaysMember 2018-01-22 0001187953 celz:ConvertibleDebt53000Member 2018-02-01 2018-02-15 0001187953 celz:ConvertibleDebt53000Member srt:MaximumMember 2018-02-01 2018-02-15 0001187953 celz:ConvertibleDebt53000Member 2018-02-15 0001187953 celz:RedeemableConvertibleDebenturesMaturityPeriodwithin90DaysMember 2018-02-15 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodBetween91And179DaysMember 2018-02-15 0001187953 celz:ConvertibleDebt53000Member 2018-04-01 2018-04-26 0001187953 celz:ConvertibleDebt53000Member 2018-04-26 0001187953 celz:ConvertibleDebt27500Member 2018-03-01 2018-03-09 0001187953 celz:ConvertibleDebt27500Member srt:MaximumMember 2018-03-01 2018-03-09 0001187953 celz:ConvertibleDebt60000Member 2018-03-01 2018-03-09 0001187953 celz:ConvertibleDebt60000Member 2018-03-09 0001187953 celz:ConvertibleDebt27500Member 2018-03-09 0001187953 celz:ConvertibleDebt27500Member celz:RedeemableConvertibleDebenturesMaturityPeriodwithin30DaysMember 2018-03-09 0001187953 celz:ConvertibleDebt27500Member celz:RedeemableConvertibleDebenturesmaturityPeriodBetween31And60DaysMember 2018-03-09 0001187953 celz:ConvertibleDebt27500Member celz:RedeemableConvertibleDebenturesmaturityPeriodBetween61And90DaysMember 2018-03-09 0001187953 celz:ConvertibleDebt27500Member celz:RedeemableConvertibleDebenturesmaturityPeriodBetween91And120DaysMember 2018-03-09 0001187953 celz:ConvertibleDebt27500Member celz:RedeemableConvertibleDebenturesmaturityPeriodbetween121And150DaysMember 2018-03-09 0001187953 celz:ConvertibleDebt27500Member celz:RedeemableConvertibleDebenturesmaturityPeriodbetween151And180DaysMember 2018-03-09 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodafter180DaysMember 2018-03-09 0001187953 celz:ConvertibleDebt115000Member 2018-02-26 2018-03-13 0001187953 celz:ConvertibleDebt115000Member srt:MaximumMember 2018-02-26 2018-03-13 0001187953 celz:ConvertibleDebt115000Member 2018-03-13 0001187953 celz:RedeemableConvertibleDebenturesMaturityPeriodwithin90DaysMember 2018-03-13 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodBetween91And179DaysMember 2018-03-13 0001187953 celz:ConvertibleDebt48000Member 2018-03-01 2018-03-15 0001187953 celz:ConvertibleDebt48000Member 2018-03-15 0001187953 celz:RedeemableConvertibleDebenturesMaturityPeriodWithin60DaysMember 2018-03-15 0001187953 celz:RedeemableConvertibleDebenturesMaturityPeriodBetween61And120DaysMember 2018-03-15 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodBetween121And180DaysMember 2018-03-15 0001187953 celz:ConvertibleDebt48000Member 2018-04-01 2018-04-25 0001187953 celz:ConvertibleDebt48000Member 2018-04-25 0001187953 celz:ConvertibleDebt110000Member 2018-04-01 2018-04-03 0001187953 celz:ConvertibleDebt110000Member 2018-04-03 0001187953 celz:RedeemableConvertibleDebenturesMaturityPeriodwithin180DaysMember 2018-04-03 0001187953 celz:ConvertibleDebt110000FourthManMember 2018-04-11 0001187953 celz:RedeemableConvertibleDebenturesMaturityPeriodwithin180DaysMember 2018-04-11 0001187953 celz:ConvertibleDebt110000PowerupMember 2018-04-13 0001187953 celz:RedeemableConvertibleDebenturesMaturityPeriodwithin30DaysMember 2018-04-13 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodBetween31And60DaysMember 2018-04-13 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodBetween61And90DaysMember 2018-04-13 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodBetween91And120DaysMember 2018-04-13 0001187953 celz:RedeemableConvertibleDebenturesmaturityPeriodbetween121And150DaysMember 2018-04-13 0001187953 celz:ConvertibleDebt110000PowerupMember celz:RedeemableConvertibleDebenturesmaturityPeriodbetween151And180DaysMember 2018-04-13 0001187953 celz:ConvertibleDebt108000Member 2018-05-14 0001187953 celz:ConvertibleDebt108000GlobalMember 2018-05-14 0001187953 celz:ConvertibleDebt108000GlobalMember 2018-06-27 0001187953 celz:ConvertibleNote108000Global2Member 2018-08-01 2018-08-08 0001187953 celz:ConvertibleNoteAuctusMember 2018-08-01 2018-08-08 0001187953 celz:ConvertibleDebt108000Member 2018-05-01 2018-05-14 0001187953 celz:ConvertibleDebt108000GlobalMember 2018-05-01 2018-05-14 0001187953 celz:ConvertibleDebt110000PowerupMember 2018-04-01 2018-04-13 0001187953 celz:ConvertibleDebt110000PowerupMember srt:MaximumMember 2018-04-01 2018-04-13 0001187953 celz:ConvertibleNote108000Global2Member 2018-08-08 0001187953 celz:ConvertibleNote183250GlobalMember 2018-09-20 0001187953 celz:ConvertibleNote183250MorningviewMember 2018-09-20 0001187953 celz:ConvertibleDebt183250FourthManMember 2018-09-20 0001187953 celz:ConvertibleNote183250GlobalMember 2018-09-01 2018-09-20 0001187953 celz:ConvertibleDebt183250FourthManMember 2018-09-01 2018-09-20 0001187953 celz:ConvertibleNote183250MorningviewMember 2018-09-01 2018-09-20 0001187953 celz:ConvertibleNote183250GlobalMember srt:MaximumMember 2018-09-01 2018-09-20 0001187953 celz:ConvertibleNote183250MorningviewMember srt:MaximumMember 2018-09-01 2018-09-20 0001187953 celz:ConvertibleDebt183250FourthManMember srt:MaximumMember 2018-09-01 2018-09-20 0001187953 us-gaap:LicensingAgreementsMember 2017-01-01 2017-12-31 0001187953 celz:ConvertibleDebt44000Member 2018-07-01 2018-07-16 0001187953 celz:ConvertibleDebt44000Member 2018-07-16 0001187953 celz:CreativeMedicalHealthMember celz:MayNoteOneMember 2017-07-31 0001187953 celz:ConvertibleDebt400000Member 2018-03-01 2018-03-23 0001187953 celz:ConvertibleDebt108000GlobalMember 2018-06-01 2018-06-27 0001187953 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2018-10-16 2018-10-22 0001187953 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2018-11-01 2018-11-12 0001187953 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2018-10-01 2018-10-18 0001187953 celz:NotesMember 2017-12-31 0001187953 us-gaap:WarrantMember 2017-12-31 0001187953 celz:NotesMember 2018-09-30 0001187953 us-gaap:WarrantMember 2018-09-30 172832 13697 14000 4801 186832 18498 168791 184649 355623 203147 242843 237566 29640 23140 269050 352750 214109 251748 125000 125000 0 125000 10800 10800 6818117 1309190 7709559 2435194 0 915 0 3211 7709559 2439320 0 0 3000 0 784196 114800 10874552 1074707 -19015684 -3425680 -7353936 -2236173 355623 203147 52400 0 66800 0 36395 0 41323 0 16005 0 25477 0 2884 87728 10284 172748 282670 201985 793216 748379 5286 5286 290840 294999 819358 931836 -274835 -294999 -793881 -931836 377038 129778 981341 195523 0 0 496645 919147 -372595 14311427 54530 -1296185 242817 -14796123 -250053 -1571020 -52182 -15590004 -1181889 -1571020 -52182 -15590004 0.00 0.00 -0.03 -0.01 739239617 106313750 519120610 105885362 -1181889 15858 10709 12500 0 -14311427 -54530 496645 0 9199 0 5765 90713 47133 10845 66300 -69500 -756639 -766902 0 90000 405294 0 57004 0 1378072 376250 0 100000 915774 566250 159135 -200652 13697 221868 172832 21216 6712 11100 0 0 0 5546 10319680 0 150000 0 7522727 1060315 248875 1309190 2839915 365268 3205183 -4739284 -4597397 -9336681 1948816 9691609 11640425 1109762 5708355 6818117 500000 255771846 500000 966667 73750820 2493 7479 73397 9972 0.06 0.25 20000 50000 293 879 7894 1172 100000 2500 7500 87500 10000 2027 0.05 0.5 100000 200000 100000 200000 400000 2500000 35000 1000000 269050 35000 0.3 150000 3000000 3000000 150000 2016-02-02 2016-05-01 2016-05-18 2018-04-30 2018-07-31 2018-05-18 50000 50000 25000 50000 50000 25000 9855307 400000 360000 85000 100000 0 54085 0 0 2018-01-10 115000 103250 0.1 0 4600 0 134127 145929641 2018-04-24 55000 47500 0.1 0 17863 0 2017-12-26 50000 50000 0.12 2018-07-19 50000 43000 0.05 0 0 0 0 54697 56453381 333470447 2019-01-09 30000 12500000 0.08 0 1.2 0.24 1.2 2019-01-17 44000 19000 19000 0.1 4000 2000 34324 40324 0 0 0 0 1.2 0.24 0 27518485 2019-01-22 12500 0.08 1.2 0.24 1.2 0 2019-02-15 53000 50000 0.12 3000 50000 53000 0 0 0 0 1.2 0.22 1.15 1.2 82084 279795 2019-03-09 27500 23500 0.1 27500 4000 27500 0 0 1.5 0.24 0 28344 2019-03-09 60000 0.1 0.01 1.5 0.24 1.2 154284 0 60147 2018-12-13 115000 97250 0.1 15000 2750 97250 115000 69418 0 34737400 0 1.25 0.24 1.25 1.4 2019-03-15 48000 45600 0.1 2400 45600 48000 0 0 0 0 1.2 0.24 1.1 1.24 1.38 60000 209076 2019-03-29 110000 0.1 2652 110000 55753 0.01 44055213 1.5 0.18 1.4 110000 0.1 10000 100000 110000 58164 0.01 26377915 1.5 0.18 1.4 26377915 1.5 0.22 1.15 1.2 1.25 1.3 1.35 1.4 2019-05-14 94960 5040 94960 66871 1.5 0.24 2019-09-27 108000 100000 0.08 8000 0 1.2 0.24 0 987750 987750 3205183 0.0009 0.0137 0.0029 0.0550 0 0.86 2.14 0.0203 0.0280 P1Y P5Y 2671002 6818117 919147 0.0008 0.0880 0.0234 0 0.95 2.14 0.0280 P6M P4Y10M24D 9336681 74000000 0 0.0263 0.91 0.0234 23426087 69919777 -223803769 401430751 -15200000 255772846 0.0023 11967158 115000 773641 192291 0 0 0 54085 0.001 7000000 0.001 0 0 0 0 0.001 3000000 0.001 3000000 3000000 0.001 3000000000 784794117 115399226 784194117 114799226 0 1689 1877 144112 0 100000 <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 1&#160;&#8211;&#160;ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Organization</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> &#160;-&#160;&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Creative Medical Technology Holdings, Inc., is considered to be a commercial stage company, following the commencement of sales of stem cell separation equipment and disposable kits used in our Caverstem procedure to treat ED in the fourth quarter of 2017. Our fiscal year end is December 31st. We have acquired the licensing rights for our Amniostem amniotic-based stem cell, purchased the patent for our ED and lower back pain treatments, and filed patent applications for our neurological treatments.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8211; The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period. &#160;Actual results could differ from those estimates.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8211; The accompanying unaudited condensed consolidated financial statements have been prepared without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2018 and for the three and nine month periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. The operations for the three and nine month periods ended September 30, 2018, are not necessarily indicative of the operating results for the full year.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Going Concern</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8211; The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, during the nine month period ended September 30, 2018, the Company incurred a net loss of $15,590,004 had negative cash flows from operating activities, had a working capital deficit of $7,522,727 and had minimal revenue-generating activities. These factors raise substantial doubt about the ability of the Company to continue as a going concern. In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of equity securities. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Revenue</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> - The Company recognizes revenue as it is earned as defined by U.S. GAAP. We have adopted the new revenue recognition standard ASC 606&#160;that went into effect on January 1, 2018&#160;and determined there was no material impact to the Company&#8217;s financial statements. All revenues reported in 2018 and beyond will reflect those standards.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value of Financial Instruments&#160;</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;- The Company&#8217;s financial instruments consist of cash and cash equivalents, convertible notes, and payables.&#160;&#160;The carrying amount of cash and cash equivalents and payables approximates fair value because of the short-term nature of these items.</div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">When determining fair value, whenever possible the Company uses observable market data, and relies on unobservable inputs only when observable market data is not available. As of September 30, 2018 and December 31, 2017, the Company didn&#8217;t have any Level 1 or 2 financial instruments. The table below reflects the results of our Level 3 fair value calculations:</div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; margin-left: 0.5in; width: 85%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 61%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Derivative liability at December 31, 2017</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,060,315</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">248,875</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,309,190</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Addition of new conversion option derivatives</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,839,915</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">365,268</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">3,205,183</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Conversion of note derivatives</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,739,284</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,597,397</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(9,336,681</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,948,816</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">9,691,609</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">11,640,425</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Derivative liability at September 30, 2018</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,109,762</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">5,708,355</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">6,818,117</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Basic and Diluted Loss Per Share&#160;&#8211; </div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company follows Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 260 Earnings per Share to account for earnings per share. Basic earnings per share (&#8220;EPS&#8221;) calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. During the three and nine month periods ended September 30, 2018, the Company had 500,000 options and 255,771,846 warrants to purchase common stock outstanding. During the three and nine month periods ended September 30, 2017, the Company had 500,000 options and 966,667 warrants to purchase common stock outstanding. In addition, the Company has various convertible notes payable which at September 30, 2018 are convertible into approximately 73,750,820 shares of common stock. The effects of the dilutive securities were anti-dilutive due to net&#160;loss&#160;during&#160;the&#160;three&#160;and&#160;nine&#160;month&#160;periods&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ended September 30, 2018 and 2017.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements &#8211;</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> In July 2017, the FASB issued ASU No. 2017-11, &#8220;Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815),&#8221; which addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements other than disclosed above.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8211; The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period. &#160;Actual results could differ from those estimates.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8211; The accompanying unaudited condensed consolidated financial statements have been prepared without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2018 and for the three and nine month periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. The operations for the three and nine month periods ended September 30, 2018, are not necessarily indicative of the operating results for the full year.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Going Concern</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8211; The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, during the nine month period ended September 30, 2018, the Company incurred a net loss of $15,590,004 had negative cash flows from operating activities, had a working capital deficit of $7,522,727 and had minimal revenue-generating activities. These factors raise substantial doubt about the ability of the Company to continue as a going concern. In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of equity securities. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Revenue</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> - The Company recognizes revenue as it is earned as defined by U.S. GAAP. We have adopted the new revenue recognition standard ASC 606&#160;that went into effect on January 1, 2018&#160;and determined there was no material impact to the Company&#8217;s financial statements. All revenues reported in 2018 and beyond will reflect those standards.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value of Financial Instruments&#160;</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;- The Company&#8217;s financial instruments consist of cash and cash equivalents, convertible notes, and payables.&#160;&#160;The carrying amount of cash and cash equivalents and payables approximates fair value because of the short-term nature of these items.</div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">When determining fair value, whenever possible the Company uses observable market data, and relies on unobservable inputs only when observable market data is not available. As of September 30, 2018 and December 31, 2017, the Company didn&#8217;t have any Level 1 or 2 financial instruments. The table below reflects the results of our Level 3 fair value calculations:</div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; margin-left: 0.5in; width: 85%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 61%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Derivative liability at December 31, 2017</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,060,315</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">248,875</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,309,190</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Addition of new conversion option derivatives</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,839,915</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">365,268</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">3,205,183</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Conversion of note derivatives</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,739,284</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,597,397</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(9,336,681</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,948,816</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">9,691,609</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">11,640,425</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Derivative liability at September 30, 2018</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,109,762</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">5,708,355</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">6,818,117</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Basic and Diluted Loss Per Share&#160;&#8211; </div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company follows Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 260 Earnings per Share to account for earnings per share. Basic earnings per share (&#8220;EPS&#8221;) calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. During the three and nine month periods ended September 30, 2018, the Company had 500,000 options and 255,771,846 warrants to purchase common stock outstanding. During the three and nine month periods ended September 30, 2017, the Company had 500,000 options and 966,667 warrants to purchase common stock outstanding. In addition, the Company has various convertible notes payable which at September 30, 2018 are convertible into approximately 73,750,820 shares of common stock. The effects of the dilutive securities were anti-dilutive due to net&#160;loss&#160;during&#160;the&#160;three&#160;and&#160;nine&#160;month&#160;periods&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ended September 30, 2018 and 2017.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements &#8211;</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> In July 2017, the FASB issued ASU No. 2017-11, &#8220;Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815),&#8221; which addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements other than disclosed above.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; margin-left: 0.5in; width: 85%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Notes</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 61%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Derivative liability at December 31, 2017</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,060,315</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">248,875</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,309,190</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Addition of new conversion option derivatives</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,839,915</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">365,268</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">3,205,183</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Conversion of note derivatives</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,739,284</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,597,397</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(9,336,681</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,948,816</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">9,691,609</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">11,640,425</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Derivative liability at September 30, 2018</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1,109,762</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">5,708,355</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">6,818,117</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 2&#160;&#8211;&#160;LICENSING AGREEMENTS</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">ED Patent</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8211; The Company acquired a patent from CMH. </div><div style="white-space: pre-line; background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Amortization expense of $2,493 and $7,479 were recorded for the three month and nine months periods ended September 30, 2018, respectively. </div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2018, the carrying value of the patent was $73,397. The Company expects to amortize approximately $9,972 annually through 2026 related to the patent costs.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Male Infertility License Agreement -</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> The Company has acquired a royalty license from Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (&#8220; </div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">LABIOMED</div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8221;) granting the exclusive license to the products and services of a LABIOMED patent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is subject to a 6% royalty payment to LABIOMED on net sales of any products under this license and 25% on any non-royalty sublicense income. Commencing in 2019, and each subsequent year thereafter, the Company is required to pay to LABIOMED annual maintenance royalties of $20,000, unless during the prior one-year period the Company paid $50,000 or more in actual royalty payments. Finally, the Company agreed to pay LABIOMED certain milestone payments upon achieving the milestones set forth in the agreement. As of September 30, 2018, no amounts are currently due to LABIOMED.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Multipotent Amniotic Fetal Stem Cells License Agreement -</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> In August 2016, CMT entered into a License Agreement with a University. This license agreement grants to CMT the exclusive right to all products derived from a patent for use of multipotent amniotic fetal stem cells composition of matter throughout the world during the period ending on the expiration date of the longest-lived patent rights under the patent. CMT paid the University an initial license fee within 30 days of entering into the agreement. CMT is also required to pay annual license maintenance fees on each anniversary date of the agreement, which maintenance fees would be credited toward any earned royalties for any given period. The License Agreement provides for payment of various milestone payments and earned royalties on the net sales of licensed products by CMT or any sub licensee. CMT is also required to reimburse the University for any future costs associated with maintaining the patent. CMT may terminate the license agreement for any reason upon 90 days&#8217; written notice and the University may terminate the agreement in the event CMT fails to meet its obligations set forth therein, unless the breach is cured within 30 days of the notice from the University specifying the breach. CMT is also obligated to indemnify the University against claims arising due to the exercise of the license by CMT or any sub licensee. As of September 30, 2018, no amounts are currently due to the University.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company estimates that the patent expires in February 2026 and has elected to amortize the patent through the period of expiration on a straight line basis. Amortization expense of $293 and $879 were recorded for the three and nine month periods ended September 30, 2018</div><div style="white-space: pre-line; background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">, respectively. </div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2018, the carrying value of the patent was $7,894. The Company expects to amortize approximately $1,172 annually through 2026 related to the patent costs.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Lower Back Patent</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> &#8211; The Company, through a newly created subsidiary of CMT, StemSpine, LLC, acquired a patent from CMH, a related company, on May 17, 2017, for $100,000, payable in cash or stock. The patent expires on May 19, 2027 and the Company has elected to amortize the patent over a ten-year period on a straight line basis. Amortization expense of $2,500 and $7,500 were recorded for the three and nine month periods ended September 30, 2018, respectively. As of September 30, 2018, the carrying value of the patent was $87,500. The company expects to amortize approximately $10,000 annually through 2027 related to the patent costs.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For a period of five years from the date of the first sale of any product derived from the patent, StemSpine is required to make royalty payments of 5% from gross sales of products. StemSpine has also agreed to pay royalties of 50% of sale price or ongoing payments from third parties for licenses granted under the patent to third parties. In addition, StemSpine has agreed to make progress payments under the patent purchase agreement determined by whether the technology represented by the patent is tested by use of autologous cells or allogenic cells. In the case of pursuit of the technology using autologous cells, StemSpine has agreed to pay CMH $100,000 upon the signing of an agreement with a university for the initiation of an IRB clinical trial and $200,000 upon completion of the clinical trial. In the event StemSpine determines to pursue the technology using allogenic cells, StemSpine has agreed to pay CMH $100,000 upon the filing for IND with the FDA; $200,000 upon the dosing of the first patient in Phase 1-2 clinical trial; and $400,000 upon the dosing of the first patient in Phase 3 clinical trial. In each case StemSpine has the option to make these payments in cash or in shares of the Company&#8217;s common stock at a discount to the market price of the stock at the time of the transaction. The parties to the patent purchase agreement have agreed that in no event will the aggregate royalty payments under the agreement exceed $2,500,000.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 3&#160;&#8211;&#160;RELATED PARTY TRANSACTIONS</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has incurred a monetary obligation to a related corporation to reimburse the cost of services provided to the Company (management and consulting) through September 30, 2018. Each of the Company&#8217;s executive officers is employed by the parent company, CMH, and will continue to receive his or her salary or compensation from CMH. The Company has an agreement with CMH which obligates the Company to reimburse CMH $35,000 per month for such services beginning January 2016. The compensation paid by CMH will include an allocation of services performed for CMH and for the Company. The amounts are presented as a &#8220;management fee payable - related party&#8221; on the accompanying unaudited condensed consolidated balance sheets. The liability is non-interest bearing, unsecured, and will be due upon the Company successfully raising at least $1,000,000 through the sale of equity. As of September 30, 2018, amounts due to CMH under the arrangement were $269,050.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On November 17, 2017, the Company entered into a Management Reimbursement Agreement dated November 17, 2017, with Creative Medical Technologies, Inc. (&#8220; CMT &#8221;), the wholly owned subsidiary of the Company, and with Creative Medical Health, Inc., the parent of the Company (&#8220; CMH &#8221;). The Agreement memorializes the arrangement between the parties whereby the Company has, since January 1, 2016, reimbursed CMH $35,000 per month for the services of management and consultants employed by CMH and performing services for the Company and CMT. At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days&#8217; prior written notice.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 12, 2018, the Company entered into a Debt Settlement Agreement with Creative Medical Health, Inc., the parent of the Company, to exchange $150,000 in management fees owed to Creative Medical Health, Inc. in exchange for 3,000,000 shares of Series A Preferred Stock. In turn, Creative Medical Health, Inc. entered into a Debt Settlement Agreement with Timothy Warbington, our CEO, Chairman, and principal shareholder to transfer the 3,000,000 shares of Series A Preferred Stock in exchange for $150,000 of unpaid compensation owed to Mr. Warbington.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During 2016, the Company entered into three note payable agreements with CMH in which the proceeds were used in operations. The notes payable were dated February 2, 2016, May 1, 2016 and May 18, 2016 and resulted in borrowings of $50,000, $50,000 and $25,000, respectively. Notes payable of $50,000 mature on April 30, 2018, $50,000 on July 31, 2018 and $25,000 on May 18, 2018. On May 4, 2017, CMT and CMH entered into a Note Extension and Limited Waiver Agreement whereby the parties extended the maturity date of the 8% Promissory Note dated February 2, 2016, in the principal amount of $50,000, from April 30, 2017, to April 30, 2018, and CMH waived the nonpayment of the Note by CMT on the original maturity date. On extension, CMT paid to CMH accrued interest related to the extended note of $4,050. On July 31, 2017, CMT and CMH entered into a Note Extension and Limited Waiver Agreement whereby the parties extended the maturity date of the 8% Promissory Note dated May 1, 2016, in the principal amount of $50,000, from July 31, 2017, to July 31, 2018, and CMH waived the nonpayment of the Note by CMT on the original maturity date. On extension, CMT paid to CMH accrued interest related to the extended note of $4,050. The notes incur interest at 8% per annum on the outstanding balance of the notes.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 11, 2018 CMH converted the total principal and accrued interest on all three notes into 9,855,307 shares of common stock.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">See Note 2 for discussion of an additional related party transaction with CMH.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days&#8217; prior written notice.<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 4&#160;&#8211;&#160;DEBT</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$400,000 Convertible Debenture &#8211; Peak One &#8211; Note 5</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On May 2, 2017, the Company entered into a convertible debenture agreement with a third party for an aggregate principal amount of up to $400,000, for which up to $360,000 in proceeds is to be received. On May 2, 2017, the Company received the first tranche of proceeds of $85,000 for which the Company issued a convertible debenture in the face amount of $100,000. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $54,085 to interest expense respectively. As of September 30, 2018, a discount of $0 remained. During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal into 0 shares of common stock and $54,200 of principal into 23,485,183 shares of common stock respectively. On March 23, 2018, the Company paid the lender $1,000 to extinguish the remaining principal balance. As of September 30, 2018 the Company had fulfilled all the obligations of the debenture.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$115,000 Convertible Note &#8211; Auctus &#8211; Note 6</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 10, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $115,000, for which $103,250 in proceeds were received on May 5, 2017. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of January 10, 2018. The note holder has notified the company they do not consider the note in default and their intent is to continue converting the remaining principal and accrued interest into common shares. During the three and nine month periods ended September 30, 2018, the Company amortized $0 and $4,600 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature and the warrants as derivative liabilities, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. During the three and nine month periods ended September 30, 2018, the lender did&#160;not&#160;convert&#160;any&#160;principal, interest and fees into common shares&#160;and&#160;converted $134,127 of principal, interest and fees into 145,929,641 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$55,000 Convertible Note &#8211; Global &#8211; Note 7</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 24, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $55,000, for which $47,500 in proceeds were received on May 8, 2017. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of April 24, 2018. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $17,863 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature and the warrants as derivative liabilities, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. During the three and nine month periods ended September 30, 2018, the lender did&#160;not&#160;convert&#160;any&#160;principal, interest and fees into common shares&#160;and&#160;converted&#160;$47,613 of principal, interest and fees into 31,442,665 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$50,000 Secured Convertible Note &#8211; WBRE &#8211; Note 8</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On June 26, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $50,000, for which $50,000 in proceeds were received on September 26, 2017. Under the terms of the agreement, the convertible note incurs interest at 12% per annum and matured on December 26, 2017. The convertible note has since been retired through a debt exchange agreement with a third party dated March 8, 2018, see "$60,000 Convertible Note" below.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$50,000 Convertible Note &#8211; Crown Bridge &#8211; Note 9</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On July 19, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $50,000, for which $43,000 in proceeds were received on July 25, 2017. Under the terms of the agreement, the convertible note incurs interest at 5% per annum and has a maturity date of July 19, 2018. During the three and nine month ended September 30, 2018 the Company amortized $0 and $27,397 respectively to interest expense. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $54,697 of principal, interest and fees into 56,453,381 common shares respectively. As of September 30, 2018 there were 333,470,447 common shares reserved with our transfer agent. As of September 30, 2018 the Company had fulfilled all the obligations of the note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$30,000 Convertible Note &#8211; Global &#8211; Note 14</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $30,000, for which 12,500,000 outstanding warrants from the convertible note dated April 24, 2017 were extinguished. The difference between the convertible note, the conversion feature and the value of the warrants was recorded as a derivative loss. No proceeds were received in conjunction with this note. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of January 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of up to 0 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes at any time within 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three and nine month periods ended September 30, 2018, the lender converted $5,000 of principal, interest and fees into 816,994 common shares and $32,744 of principal, interest and fees into 5,350,345 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$44,000 Convertible Note &#8211; Adar Bays &#8211; Note 15</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 17, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $44,000, for which $19,000 in proceeds were received on January 23, 2018 and $19,000 in proceeds were received on February 26, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of January 17, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing the on issuance discount of $4,000, legal fees of $2,000 and the remaining discount of $34,324 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $40,324 to interest expense using the straight-line method over the term of the loan. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $40,324 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">There is no option for the Company to redeem the convertible note prior to maturity.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $44,000 of principal, interest and fees into 27,518,485 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In connection with the original agreement, the holder had the option to fund three additional $44,000 back end convertible notes. On July 16, 2018, the holder exercised this option and entered into three separate $44,000 convertible notes totaling $132,000. For which the Company received a total of $114,000 in net proceeds. Under the terms of the agreements, the convertible notes incurred interest at 10% per annum and has a maturity date of January 17, 2019. The convertible note are convertible upon issuance at a fixed price of $0.025 per share. The Company is amortizing the on issuance discount of $18,000 and the remaining discount of $114,000 due to the recording of a beneficiation conversion feature. In July and August 2018, the convertible notes were converted into 5,280,000 shares of common stock. The Company amortized the entire discount of $132,000 to interest expense during the three and nine months ended September 30, 2018. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$12,500 Convertible Note &#8211; Global &#8211; Note 16</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 22, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $12,500, in exchange for the release of reserved shares to the Company. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of January 22, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible note within 180 days from the date of issuance at 120% of the principal and interest. After 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $12,925 of principal, interest and fees into 2,111,873 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$53,000 Convertible Note &#8211; PowerUp &#8211; Loan 17</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On February 15, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $53,000, for which $50,000 in proceeds were received on February 22, 2018 . Under the terms of the agreement, the convertible note incurs interest at 12% per annum and has a maturity date of February 15, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 61% of the average of the two lowest traded prices of the Company&#8217;s common stock during the previous 15 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing the on issuance discount of $3,000 and the remaining discount of $50,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $53,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $0 and $53,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of up to 0 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 22%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes within 90 days from the date of issuance at 115% of the principal and interest; between 91 and to 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 26, 2018 the Company retired the note with a payment of $82,084 to the note holder. A derivative liability gain of $279,795 was recorded to reflect the retirement of the derivative liability.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$27,500 Convertible Note &#8211; Global &#8211; Note 18</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On March 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $27,500, for which proceeds of $23,500 were received on March 9, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is amortizing the discount of $27,500 due to on issuance discount of $4,000 and the recording of a derivative liability as discussed in Note 5. The Company is amortizing the discount of $27,500 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $0 and $27,500 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes within 30 days from the date of issuance at 115% of the principal and interest; between 31 and to 60 days from the date of issuance at 120% of the principal and interest; between 61 and to 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 120 days from the date of issuance at 130% of the principal and interest; between 121 and to 150 days from the date of issuance at 135% of the principal and interest; between 151 and 180 days from issuance at 140% of principal and interest; and after 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $28,344 of principal, interest and fees into 4,631,346 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$60,000 Convertible Note &#8211; Global &#8211; WBRE Exchange &#8211; Note 19</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">March 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $60,000, in exchange for the extinguishment of the outstanding principal due on the convertible note dated September 26, 2017, see disclosure above for "</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$50,000 Secured Convertible Note".</div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> No proceeds were received in conjunction with the exchange of this convertible note. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. At no additional cost, we issued to the note holder 30,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.&#160;&#160;The warrants are exercisable on a cashless basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">At the date of the agreement, the Company determined that the transactions qualified for extinguishment accounting whereby the transaction was accounted for at fair market value with the excess value between the fair value of the old note and new note was accounted for as an extinguishment loss of $154,284.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $60,147 of principal, interest and fees into 45,665,203 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$115,000 Convertible Note &#8211; Auctus &#8211; Note 20</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On March 13, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $115,000, for which $97,250 in proceeds were received on March 19, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of December 13, 2018. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the average of the two lowest traded prices of the Company&#8217;s common stock during the previous 25 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to six times the number of common shares the convertible note is convertible into. The Company is amortizing the original issuance discount of $15,000 legal fees of $2,750 and the remaining discount of $97,250 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $115,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month periods ended September 30, 2018 the Company amortized $69,418 and $115,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 34,737,400 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 125% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes within 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 180 days from the date of issuance at 140% of the principal and interest; and after 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three and nine month periods ended September 30, 2018, the lender converted $43,769 of principal, interest and fees into 34,737,400 common shares. On August 8, 2018, the Company retired the note and accrued interest with a payment of $106,312 to the note holder, which included a prepayment fee of $30,128 recorded within interest expense.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$48,000 Convertible Note &#8211; GS &#8211; Note 21</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On March 15, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $48,000, for which $45,600 in proceeds were received on March 20, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 15, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 63% of the average of the two lowest traded prices of the Company&#8217;s common stock during the previous 12 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to six times the number of common shares the convertible note is convertible into. The Company is amortizing legal fees of $2,400 and the remaining discount of $45,600 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $48,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $0 and $48,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes within 60 days from the date of issuance at 110% of the principal and interest; between 61 and to 120 days from the date of issuance at 124% of the principal and interest; between 121 days and to 180 days from the date of issuance at 138%; and after 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 25, 2018 the Company retired the note with a payment of $60,000 to the note holder. A derivative liability gain of $209,076 was recorded to reflect the retirement of the derivative liability.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$110,000 Convertible Note &#8211; Morningview &#8211; Note 22</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 3, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $95,000 in proceeds were received on April 3, 2018 . Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 29, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to five times the number of common shares the convertible note is convertible into. The Company is amortizing legal fees of $2,652 and the remaining discount of $107,348 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and nine months ended September 30, 2018 the Company amortized $27,726 and $54,247 to interest expense respectively. As of September 30, 2018, a discount of $55,753 remained. At no additional cost, we issued to the note holder 11,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.&#160;&#160;The warrants are exercisable on a cashless basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 84,110,033 shares reserved with our transfer agent with a potential of 44,055,213 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 18%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 140% of the principal and interest. After 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$110,000 Convertible Note &#8211; Fourth Man &#8211; Note 23</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 11, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $100,000 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity 12 months from the effective date of payment. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $10,000 and the remaining discount of $100,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $27,726 and $51,836 to interest expense respectively. As of September 30, 2018, a discount of $58,164 remained. At no additional cost, we issued to the note holder 11,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.&#160;&#160;The warrants are exercisable on a cashless basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 18,333,333 shares reserved with our transfer agent with a potential of 26,377,915 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 18%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 140% of the principal and interest. After 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$110,000 Convertible Note &#8211; Power Up &#8211; Note 24</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 13, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $99,000 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 29, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $10,000, legal fees of $1,000 and the remaining discount of $99,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $27,726 and $51,836 to interest expense respectively. As of September 30, 2018, a discount of $58,164 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 13,000,000 shares reserved with our transfer agent with a potential of 26,377,915 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 22%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the convertible notes within 30 days from the date of issuance at 115% of the principal and interest; between 31 and to 60 days from the date of issuance at 120% of the principal and interest; between 61 and to 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 120 days from the date of issuance at 130% of the principal and interest; between 121 and to 150 days from the date of issuance at 135% of the principal and interest; between 151 and to 180 days from the date of issuance at 140% of the principal and interest; and after 180 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$108,000 Convertible Note &#8211; Global &#8211; Note 25</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On May 14, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $108,000, for which $94,960 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of May 14, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $8,000, legal fees of $5,040 and the remaining discount of $94,960 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $108,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $27,222 and $41,129 to interest expense. As of September 30, 2018, a discount of $66,871 remained. At no additional cost, we issued to the note holder 3,600,000 five-year warrants to purchase common stock at $0.025, subject to adjustment if we issue securities at less than the exercise price.&#160;&#160;The warrants are exercisable on a cashless basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 35,000,000 shares reserved with our transfer agent with a potential of 25,486,329 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">There is no option to pre-pay this note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$108,000 Note &#8211; Global &#8211; Note 26</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On June 27, 2018, the Company entered into a note agreement with a third party for an aggregate principal amount of $108,000, for which $100,000 in proceeds were received. Under the terms of the agreement, the note incurs interest at 8% per annum and has a maturity date of September 27, 2019. The Company is amortizing the on-issuance discount of $8,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $1,797 and $1,863 and to interest expense respectively. On September 20, 2018, this note was combined with other notes disclosed below, a portion of which was repaid with the remainder being rolled into Global - Note 28 disclosed below. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$108,000 Note &#8211; Global &#8211; Note 27</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On August 8, 2018, the Company entered into a note agreement with a third party for an aggregate principal amount of $108,000, for which $106,500 in proceeds were received. Under the terms of the agreement, the note incurs interest at 8% per annum and has a maturity date of August 8, 2019. The Company is amortizing the on-issuance discount of $1,500 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $177 to interest expense. On September 20, 2018, this note was combined with other notes disclosed immediately above and below, a portion of which was repaid with the remainder being rolled into Global - Note 28 disclosed below. As of September 30, 2018, a discount of $0 remained.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$183,250 Convertible Note &#8211; Global &#8211; Note 28</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $100,000 in proceeds were received and remaining balances convertible notes disclosed above were rolled over. At the time of combination, the total carrying amount outstanding under the prior notes was $211,570. In connection, with the agreement, Global was paid $139,352, principal of $69,676 rolled into the new note and a gain of $2,542 was recorded within interest expense. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company&#8217;s stock at a conversion price equal to 65% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574 and the remaining discount of $169,676 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.&#160;&#160;The warrants are exercisable on a cashless basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$183,250 Convertible Note &#8211; Morningview &#8211; Note 29</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $169,676 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company&#8217;s stock at a conversion price equal to 65% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574, legal fees of $8,363 and the remaining discount of $161,313 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.&#160;&#160;The warrants are exercisable on a cashless basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">$183,250 Convertible Note &#8211; Fourth Man &#8211; Note 29</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $169,676 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company&#8217;s stock at a conversion price equal to 65% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company&#8217;s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574, legal fees of $8,363 and the remaining discount of $161,313 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.&#160;&#160;The warrants are exercisable on a cashless basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company&#8217;s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the Company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2018, future loan maturities are as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 70%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended December 31,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 85%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2018</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2019</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">987,750</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">987,750</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 60000 5000 816994 32744 5350345 4631346 <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2018, future loan maturities are as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 70%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended December 31,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 85%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2018</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2019</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">987,750</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">987,750</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 23485183 0 54200 47613 31442665 27397 53000 27500 115000 48000 54247 51836 27726 51836 27222 41129 40324 0 84110033 18333333 13000000 25486329 25000000 38859058 25000000 38859058 25000000 38859058 0 45665203 43769 34737400 43769 34737400 183250 169676 183250 169676 183250 100000 108000 106500 110000 99000 108000 100000 95000 <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 6&#160;&#8211;&#160;WARRANTS</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The fair value of each warrant is estimated using the Black-Scholes valuation model. Assumptions used in calculating the fair value at September 30, 2018 were as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 85%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted </div></div><br/><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average </div></div><br/><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs Used</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Annual dividend yield</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Expected life (years)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">3.8 to 4.9</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 81%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 16%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.63</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">91</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stock price</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0.0234</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Since the expected life of the options was greater than the Company&#8217;s historical stock information available, the Public Company determined the expected volatility based on price fluctuations of comparable public companies.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The issuances, exercises and pricing re-sets during the nine months ended September 30, 2018 are as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 85%;"><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80.9%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at December 31, 2017</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 0.9%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1.3%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 15.9%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">23,426,087</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 0.9%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Issuances</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">69,919,777</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercises</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(223,803,769</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;">)</div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Anti-Dilution/Modification</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">401,430,751</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Forfeitures/cancellations</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(15,200,000</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;">)</div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at September 30, 2018</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">255,772,846</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Weighted Average Price at September 30, 2018</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0.0023</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The fair value of each warrant is estimated using the Black-Scholes valuation model. Assumptions used in calculating the fair value at September 30, 2018 were as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 85%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted </div></div><br/><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average </div></div><br/><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs Used</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Annual dividend yield</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Expected life (years)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">3.8 to 4.9</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 81%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 16%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.63</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">91</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stock price</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0.0234</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The issuances, exercises and pricing re-sets during the nine months ended September 30, 2018 are as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 85%;"><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80.9%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at December 31, 2017</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 0.9%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1.3%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 15.9%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">23,426,087</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 0.9%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Issuances</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">69,919,777</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercises</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(223,803,769</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;">)</div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Anti-Dilution/Modification</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">401,430,751</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Forfeitures/cancellations</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(15,200,000</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;">)</div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at September 30, 2018</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">255,772,846</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: justify; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Weighted Average Price at September 30, 2018</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0.0023</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> P3Y9M18D P4Y10M24D <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 5&#160;&#8211;&#160;DERIVATIVE LIABILITIES</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Derivative Liabilities</div></div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.5in; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In connection with convertible notes payable, the Company records derivative liabilities for the conversion feature. In addition, the Company has warrants for which the exercise prices reset upon future events. These warrants are also considered to be derivative liabilities. The derivative liabilities are valued on the date the convertible note payable become convertible and revalued at each reporting period. The warrants are valued on the date of issuance and revalued at each reporting period. During the nine months ended September 30, 2018, the Company recorded initial derivative liabilities of $3,205,183 based upon the following Black-Scholes option pricing model average assumptions: an exercise price of $0.0009 to $0.0137 our stock price on the date of grant of $0.0029 to $0.0550, expected dividend yield of 0%, expected volatility of 86% to 214%, risk free interest rate of 2.03% to 2.80% and expected terms ranging from 1.0 to 5.0 years. Upon initial valuation, the derivative liability exceeded the face value certain of the convertible note payables by approximately $2,671,002, which was recorded as a day one loss on derivative liability.</div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 30, 2018, the derivative liabilities were revalued at $6,818,117 resulting in a loss of $919,147 related to the change in fair market value of the derivative liabilities during the three months ended September 30, 2018. The total loss related to the change in fair market value of the derivative liabilities during the nine months ended September 30, 2018 was $11,640,425. The derivative liabilities were revalued using the Black-Scholes option pricing model with the following average assumptions: an exercise price of $0.0008 to $0.0880, our stock price on the date of valuation ($0.0234), expected dividend yield of 0%, expected volatility of 95% to 214%, risk-free interest rates ranging from 2.63 - 2.80%, and an expected terms ranging from 0.5 to 4.9 years.</div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In connection with convertible notes converted and warrants exercised, as disclosed in Note 5, the Company reclassed derivative liabilities with a fair value of $9,336,681 to additional paid-in capital. The Company revalued the derivative liabilities at each conversion date recording the pro-rata portion of the derivative liability as compared to the portion of the convertible note converted to the pre-conversion carrying value to additional paid-in capital</div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Future Potential Dilution</div></div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Most of the Company&#8217;s convertible notes payable contain adjustable conversion terms with significant discounts to market. As of September 30, 2018 the Company&#8217;s convertible notes payable are potentially convertible into an aggregate of approximately 74 million shares of common stock. In addition, due to the variable conversion prices on some of the Company&#8217;s convertible notes, the number of common shares issuable is dependent upon the traded price of the Company&#8217;s common stock.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 11640425 0.0263 27726 5021 5021 5021 5021 5021 5021 1797 1863 27726 177 177 10000 1000 8000 1500 13574 8363 107348 99000 58164 0 169676 178229 13574 161313 13574 8363 161313 178229 178229 0.025 0.088 0.088 0.088 183250 183250 183250 108000 110000 1.15 1.2 1.25 1.3 1.35 1.4 1.2 0.24 The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. The convertible note is convertible upon issuance and convertible into shares of the Company&#8217;s stock at a conversion price equal to 60% of the lowest traded price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. conversion price equal to 60% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. conversion price equal to 60% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. conversion price equal to 60% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. 500000 500000 966667 255171846 114000 0 106312 132000 0.1 2019-01-17 114000 5280000 0 0.08 50000 4050 0.08 50000 4050 2017-04-30 2018-04-30 2017-07-31 2018-07-31 0.08 0.001 0 0 2111873 12925 0 0 44000 878349 173578 211570 139352 69676 2542 0.08 2019-09-20 The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company&#8217;s stock at a conversion price equal to 65% of the lowest trading price of the Company&#8217;s common stock during the previous 20 trading days preceding the conversion date. 132000 0.025 18000 30128 30000000 11000000 11000000 3600000 1247618 1247618 1247618 35000000 0 1000 114000 0.1 0.08 <div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px;"><div style="font-weight:bold;display:inline;">NOTE </div><div style="font-weight:bold;display:inline;">7 &#8211;SUBSEQUENT EVENTS</div></div><div style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; color: rgb(56, 56, 56); background: none;">&#160;</div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px;">In&#160;accordance&#160;with ASC&#160;855, management&#160;reviewed&#160;all material&#160;events&#160;through&#160;August&#160;14,&#160;2018,&#160;for these&#160;financial&#160;statements and&#160;there are no material&#160;subsequent&#160;events&#160;to&#160;report,&#160;except as follows:</div><div style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; color: rgb(90, 90, 90); background: none;"><div style="font-style:italic;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px;"><div style="font-style:italic;display:inline;">Co</div><div style="font-style:italic;display:inline;">nversion&#160;Notice</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">From October 16,&#160;2018 through October 22, 2018 we&#160;issued<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> 11,967,158 </div>shares of common stock&#160;for the&#160;conversion&#160;<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">of $115,000 </div>in&#160;convertible&#160;notes<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">On October 18, 2018 we issued 9,297,576 shares of common stock to a lender whom exercised 10,000,000 warrants in a cashless exercise.&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">On November&#160;12,&#160;2018 we issued<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> 25,055,575 </div>shares&#160;of&#160;common stock to a&#160;lender&#160;whom&#160;exercised<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> 28,200,000 </div>warrants&#160;in&#160;a cashless exercise<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 9297576 10000000 25055575 28200000 10-Q false 2018-09-30 2018 Q3 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. 0001187953 --12-31 Non-accelerated Filer CELZ 830514426 true false true 7000000 3000000 3000000000 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares EX-101.SCH 7 celz-20180930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - LICENSING AGREEMENTS link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - DEBT link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - DERIVATIVE LIABILITIES link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - WARRANTS link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - DEBT (Tables) link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - WARRANTS (Tables) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - LICENSING AGREEMENTS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - RELATED PARTY TRANSACTIONS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - DEBT (Details) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - DEBT (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - DERIVATIVE LIABILITIES (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - WARRANTS (Details) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - WARRANTS (Details 1) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - SUBSEQUENT EVENTS (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 celz-20180930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 celz-20180930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 celz-20180930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 celz-20180930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 14, 2018
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q3  
Entity Registrant Name CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.  
Entity Central Index Key 0001187953  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Trading Symbol CELZ  
Entity Common Stock, Shares Outstanding   830,514,426
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Small Business true  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2018
Dec. 31, 2017
CURRENT ASSETS    
Cash $ 172,832 $ 13,697
Accounts receivable 14,000 4,801
Total Current Assets 186,832 18,498
OTHER ASSETS    
Licenses, net of amortization 168,791 184,649
TOTAL ASSETS 355,623 203,147
CURRENT LIABILITIES    
Accounts payable 242,843 237,566
Accrued expenses 29,640 23,140
Management fee payable - related party 269,050 352,750
Convertible notes payable, net of discount of $773,641 and $192,291, respectively 214,109 251,748
Notes payable, net of discount of $0 and $0, respectively 125,000 125,000
Notes payable - related party - current 0 125,000
Advances from related party 10,800 10,800
Derivative liabilities 6,818,117 1,309,190
Total Current Liabilities 7,709,559 2,435,194
LONG TERM LIABILITIES    
Convertible notes payable, net of discount of $0 and $54,085, respectively 0 915
Accrued expenses, net of current portion 0 3,211
TOTAL LIABILITIES 7,709,559 2,439,320
Commitments and contingencies
STOCKHOLDERS' DEFICIT    
Preferred Stock 0 0
Common stock, $0.001 par value, 3,000,000,000 shares authorized; 784,794,117 and 115,399,226 issued and 784,194,117 and 114,799,226 outstanding at September 30, 2018 and December 31, 2017, respectively 784,196 114,800
Additional paid-in capital 10,874,552 1,074,707
Accumulated deficit (19,015,684) (3,425,680)
TOTAL STOCKHOLDERS' DEFICIT (7,353,936) (2,236,173)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 355,623 203,147
Series A Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred Stock $ 3,000 $ 0
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Authorized 7,000,000 7,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 3,000,000,000 3,000,000,000
Common Stock, Shares, Issued 784,794,117 115,399,226
Common Stock, Shares, Outstanding 784,194,117 114,799,226
Convertible Notes Payable [Member]    
Debt Instrument, Unamortized Discount, Current $ 773,641 $ 192,291
Debt Instrument, Unamortized Discount, Noncurrent 0 54,085
Notes Payable, Other Payables [Member]    
Debt Instrument, Unamortized Discount, Noncurrent $ 0 $ 0
Series A Preferred Stock [Member]    
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Authorized 3,000,000 3,000,000
Preferred Stock, Shares Issued 3,000,000 0
Preferred Stock, Shares Outstanding 3,000,000 0
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenues $ 52,400 $ 0 $ 66,800 $ 0
Cost of revenues 36,395 0 41,323 0
Gross profit 16,005 0 25,477 0
OPERATING EXPENSES        
Research and development 2,884 87,728 10,284 172,748
General and administrative, including stock-based compensation of $0, $1,689, $1,877 and $144,112, respectively 282,670 201,985 793,216 748,379
Amortization of patent costs 5,286 5,286 15,858 10,709
TOTAL EXPENSES 290,840 294,999 819,358 931,836
Operating loss (274,835) (294,999) (793,881) (931,836)
OTHER INCOME/(EXPENSE)        
Interest expense (377,038) (129,778) (981,341) (195,523)
Gain on extinguishment of convertible notes 0 0 496,645 0
Change in fair value of derivatives liabilities (919,147) 372,595 (14,311,427) (54,530)
Total other expense (1,296,185) 242,817 (14,796,123) (250,053)
OPERATING LOSS (1,571,020) (52,182) (15,590,004) (1,181,889)
NET LOSS $ (1,571,020) $ (52,182) $ (15,590,004) $ (1,181,889)
BASIC AND DILUTED LOSS PER SHARE $ 0.00 $ 0.00 $ (0.03) $ (0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED 739,239,617 106,313,750 519,120,610 105,885,362
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Parenthetical) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Share-based Compensation $ 0 $ 1,689 $ 1,877 $ 144,112
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (15,590,004) $ (1,181,889)
Adjustments to reconcile net loss to net cash from operating activities:    
Stock based compensation 1,877 144,112
Amortization 15,858 10,709
Amortization of debt discounts 878,349 173,578
Increase in principal balance due to penalty provision 12,500 0
Change in fair value of derivatives liabilities 14,311,427 54,530
Gain on extinguishment of convertible notes payable (496,645) 0
Changes in assets and liabilities:    
Accounts receivable (9,199) 0
Accounts payable 5,765 90,713
Accrued expenses 47,133 10,845
Management fee payable 66,300 (69,500)
Net cash used in operating activities (756,639) (766,902)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from notes payable 0 90,000
Payments on convertible notes payable (405,294) 0
Prepayment premiums paid on convertible notes payable (57,004) 0
Proceeds from convertible notes payable 1,378,072 376,250
Proceeds from sale of common stock 0 100,000
Net cash provided from financing activities 915,774 566,250
NET INCREASE (DECREASE) IN CASH 159,135 (200,652)
BEGINNING CASH BALANCE 13,697 221,868
ENDING CASH BALANCE 172,832 21,216
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash payments for interest 6,712 11,100
Cash payments for income taxes 0 0
NON-CASH FINANCING ACTIVITIES:    
Fair value of warrants issued in private placement 0 5,546
Purchase of patents with amounts due to related party 0 100,000
Conversion of notes payable, accrued interest and derivative liabilities into common stock 10,319,680 0
Conversion of management fees into preferred stock 150,000 0
Beneficial conversion feature $ 114,000 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Organization
 -  
Creative Medical Technology Holdings, Inc., is considered to be a commercial stage company, following the commencement of sales of stem cell separation equipment and disposable kits used in our Caverstem procedure to treat ED in the fourth quarter of 2017. Our fiscal year end is December 31st. We have acquired the licensing rights for our Amniostem amniotic-based stem cell, purchased the patent for our ED and lower back pain treatments, and filed patent applications for our neurological treatments.
 
Use of Estimates
– The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
 
Basis of Presentation
– The accompanying unaudited condensed consolidated financial statements have been prepared without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2018 and for the three and nine month periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. The operations for the three and nine month periods ended September 30, 2018, are not necessarily indicative of the operating results for the full year.
 
Going Concern
– The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, during the nine month period ended September 30, 2018, the Company incurred a net loss of $15,590,004 had negative cash flows from operating activities, had a working capital deficit of $7,522,727 and had minimal revenue-generating activities. These factors raise substantial doubt about the ability of the Company to continue as a going concern. In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of equity securities. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.
 
Revenue
- The Company recognizes revenue as it is earned as defined by U.S. GAAP. We have adopted the new revenue recognition standard ASC 606 that went into effect on January 1, 2018 and determined there was no material impact to the Company’s financial statements. All revenues reported in 2018 and beyond will reflect those standards.
 
Fair Value of Financial Instruments 
 
 - The Company’s financial instruments consist of cash and cash equivalents, convertible notes, and payables.  The carrying amount of cash and cash equivalents and payables approximates fair value because of the short-term nature of these items.
 
When determining fair value, whenever possible the Company uses observable market data, and relies on unobservable inputs only when observable market data is not available. As of September 30, 2018 and December 31, 2017, the Company didn’t have any Level 1 or 2 financial instruments. The table below reflects the results of our Level 3 fair value calculations:
 
 
 
Notes
 
 
Warrants
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
Derivative liability at December 31, 2017
 
$
1,060,315
 
 
$
248,875
 
 
$
1,309,190
 
Addition of new conversion option derivatives
 
 
2,839,915
 
 
 
365,268
 
 
 
3,205,183
 
Conversion of note derivatives
 
 
(4,739,284
)
 
 
(4,597,397
)
 
 
(9,336,681
)
Change in fair value
 
 
1,948,816
 
 
 
9,691,609
 
 
 
11,640,425
 
Derivative liability at September 30, 2018
 
$
1,109,762
 
 
$
5,708,355
 
 
$
6,818,117
 
 
Basic and Diluted Loss Per Share –
The Company follows Financial Accounting Standards Board (“FASB”) ASC 260 Earnings per Share to account for earnings per share. Basic earnings per share (“EPS”) calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. During the three and nine month periods ended September 30, 2018, the Company had 500,000 options and 255,771,846 warrants to purchase common stock outstanding. During the three and nine month periods ended September 30, 2017, the Company had 500,000 options and 966,667 warrants to purchase common stock outstanding. In addition, the Company has various convertible notes payable which at September 30, 2018 are convertible into approximately 73,750,820 shares of common stock. The effects of the dilutive securities were anti-dilutive due to net loss during the three and nine month periods 
ended September 30, 2018 and 2017.
 
Recent Accounting Pronouncements –
In July 2017, the FASB issued ASU No. 2017-11, “Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815),” which addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.
 
The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements other than disclosed above.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
LICENSING AGREEMENTS
9 Months Ended
Sep. 30, 2018
Licensing Agreements Disclosure [Abstract]  
Licensing Agreements Disclosure [Text Block]
NOTE 2 – LICENSING AGREEMENTS
 
ED Patent
– The Company acquired a patent from CMH.
Amortization expense of $2,493 and $7,479 were recorded for the three month and nine months periods ended September 30, 2018, respectively.
As of September 30, 2018, the carrying value of the patent was $73,397. The Company expects to amortize approximately $9,972 annually through 2026 related to the patent costs.
 
Male Infertility License Agreement -
The Company has acquired a royalty license from Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (“
LABIOMED
”) granting the exclusive license to the products and services of a LABIOMED patent.
 
The Company is subject to a 6% royalty payment to LABIOMED on net sales of any products under this license and 25% on any non-royalty sublicense income. Commencing in 2019, and each subsequent year thereafter, the Company is required to pay to LABIOMED annual maintenance royalties of $20,000, unless during the prior one-year period the Company paid $50,000 or more in actual royalty payments. Finally, the Company agreed to pay LABIOMED certain milestone payments upon achieving the milestones set forth in the agreement. As of September 30, 2018, no amounts are currently due to LABIOMED.
 
Multipotent Amniotic Fetal Stem Cells License Agreement -
In August 2016, CMT entered into a License Agreement with a University. This license agreement grants to CMT the exclusive right to all products derived from a patent for use of multipotent amniotic fetal stem cells composition of matter throughout the world during the period ending on the expiration date of the longest-lived patent rights under the patent. CMT paid the University an initial license fee within 30 days of entering into the agreement. CMT is also required to pay annual license maintenance fees on each anniversary date of the agreement, which maintenance fees would be credited toward any earned royalties for any given period. The License Agreement provides for payment of various milestone payments and earned royalties on the net sales of licensed products by CMT or any sub licensee. CMT is also required to reimburse the University for any future costs associated with maintaining the patent. CMT may terminate the license agreement for any reason upon 90 days’ written notice and the University may terminate the agreement in the event CMT fails to meet its obligations set forth therein, unless the breach is cured within 30 days of the notice from the University specifying the breach. CMT is also obligated to indemnify the University against claims arising due to the exercise of the license by CMT or any sub licensee. As of September 30, 2018, no amounts are currently due to the University.
 
The Company estimates that the patent expires in February 2026 and has elected to amortize the patent through the period of expiration on a straight line basis. Amortization expense of $293 and $879 were recorded for the three and nine month periods ended September 30, 2018
, respectively.
As of September 30, 2018, the carrying value of the patent was $7,894. The Company expects to amortize approximately $1,172 annually through 2026 related to the patent costs.
 
Lower Back Patent
– The Company, through a newly created subsidiary of CMT, StemSpine, LLC, acquired a patent from CMH, a related company, on May 17, 2017, for $100,000, payable in cash or stock. The patent expires on May 19, 2027 and the Company has elected to amortize the patent over a ten-year period on a straight line basis. Amortization expense of $2,500 and $7,500 were recorded for the three and nine month periods ended September 30, 2018, respectively. As of September 30, 2018, the carrying value of the patent was $87,500. The company expects to amortize approximately $10,000 annually through 2027 related to the patent costs.
 
For a period of five years from the date of the first sale of any product derived from the patent, StemSpine is required to make royalty payments of 5% from gross sales of products. StemSpine has also agreed to pay royalties of 50% of sale price or ongoing payments from third parties for licenses granted under the patent to third parties. In addition, StemSpine has agreed to make progress payments under the patent purchase agreement determined by whether the technology represented by the patent is tested by use of autologous cells or allogenic cells. In the case of pursuit of the technology using autologous cells, StemSpine has agreed to pay CMH $100,000 upon the signing of an agreement with a university for the initiation of an IRB clinical trial and $200,000 upon completion of the clinical trial. In the event StemSpine determines to pursue the technology using allogenic cells, StemSpine has agreed to pay CMH $100,000 upon the filing for IND with the FDA; $200,000 upon the dosing of the first patient in Phase 1-2 clinical trial; and $400,000 upon the dosing of the first patient in Phase 3 clinical trial. In each case StemSpine has the option to make these payments in cash or in shares of the Company’s common stock at a discount to the market price of the stock at the time of the transaction. The parties to the patent purchase agreement have agreed that in no event will the aggregate royalty payments under the agreement exceed $2,500,000.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2018
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
NOTE 3 – RELATED PARTY TRANSACTIONS
 
The Company has incurred a monetary obligation to a related corporation to reimburse the cost of services provided to the Company (management and consulting) through September 30, 2018. Each of the Company’s executive officers is employed by the parent company, CMH, and will continue to receive his or her salary or compensation from CMH. The Company has an agreement with CMH which obligates the Company to reimburse CMH $35,000 per month for such services beginning January 2016. The compensation paid by CMH will include an allocation of services performed for CMH and for the Company. The amounts are presented as a “management fee payable - related party” on the accompanying unaudited condensed consolidated balance sheets. The liability is non-interest bearing, unsecured, and will be due upon the Company successfully raising at least $1,000,000 through the sale of equity. As of September 30, 2018, amounts due to CMH under the arrangement were $269,050.
 
On November 17, 2017, the Company entered into a Management Reimbursement Agreement dated November 17, 2017, with Creative Medical Technologies, Inc. (“ CMT ”), the wholly owned subsidiary of the Company, and with Creative Medical Health, Inc., the parent of the Company (“ CMH ”). The Agreement memorializes the arrangement between the parties whereby the Company has, since January 1, 2016, reimbursed CMH $35,000 per month for the services of management and consultants employed by CMH and performing services for the Company and CMT. At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days’ prior written notice.
 
On January 12, 2018, the Company entered into a Debt Settlement Agreement with Creative Medical Health, Inc., the parent of the Company, to exchange $150,000 in management fees owed to Creative Medical Health, Inc. in exchange for 3,000,000 shares of Series A Preferred Stock. In turn, Creative Medical Health, Inc. entered into a Debt Settlement Agreement with Timothy Warbington, our CEO, Chairman, and principal shareholder to transfer the 3,000,000 shares of Series A Preferred Stock in exchange for $150,000 of unpaid compensation owed to Mr. Warbington.
 
During 2016, the Company entered into three note payable agreements with CMH in which the proceeds were used in operations. The notes payable were dated February 2, 2016, May 1, 2016 and May 18, 2016 and resulted in borrowings of $50,000, $50,000 and $25,000, respectively. Notes payable of $50,000 mature on April 30, 2018, $50,000 on July 31, 2018 and $25,000 on May 18, 2018. On May 4, 2017, CMT and CMH entered into a Note Extension and Limited Waiver Agreement whereby the parties extended the maturity date of the 8% Promissory Note dated February 2, 2016, in the principal amount of $50,000, from April 30, 2017, to April 30, 2018, and CMH waived the nonpayment of the Note by CMT on the original maturity date. On extension, CMT paid to CMH accrued interest related to the extended note of $4,050. On July 31, 2017, CMT and CMH entered into a Note Extension and Limited Waiver Agreement whereby the parties extended the maturity date of the 8% Promissory Note dated May 1, 2016, in the principal amount of $50,000, from July 31, 2017, to July 31, 2018, and CMH waived the nonpayment of the Note by CMT on the original maturity date. On extension, CMT paid to CMH accrued interest related to the extended note of $4,050. The notes incur interest at 8% per annum on the outstanding balance of the notes.
 
On April 11, 2018 CMH converted the total principal and accrued interest on all three notes into 9,855,307 shares of common stock.
 
See Note 2 for discussion of an additional related party transaction with CMH.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
DEBT
9 Months Ended
Sep. 30, 2018
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
NOTE 4 – DEBT
 
$400,000 Convertible Debenture – Peak One – Note 5
 
On May 2, 2017, the Company entered into a convertible debenture agreement with a third party for an aggregate principal amount of up to $400,000, for which up to $360,000 in proceeds is to be received. On May 2, 2017, the Company received the first tranche of proceeds of $85,000 for which the Company issued a convertible debenture in the face amount of $100,000. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $54,085 to interest expense respectively. As of September 30, 2018, a discount of $0 remained. During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal into 0 shares of common stock and $54,200 of principal into 23,485,183 shares of common stock respectively. On March 23, 2018, the Company paid the lender $1,000 to extinguish the remaining principal balance. As of September 30, 2018 the Company had fulfilled all the obligations of the debenture.
 
$115,000 Convertible Note – Auctus – Note 6
 
On April 10, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $115,000, for which $103,250 in proceeds were received on May 5, 2017. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of January 10, 2018. The note holder has notified the company they do not consider the note in default and their intent is to continue converting the remaining principal and accrued interest into common shares. During the three and nine month periods ended September 30, 2018, the Company amortized $0 and $4,600 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature and the warrants as derivative liabilities, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. During the three and nine month periods ended September 30, 2018, the lender did not convert any principal, interest and fees into common shares and converted $134,127 of principal, interest and fees into 145,929,641 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.
 
$55,000 Convertible Note – Global – Note 7
 
On April 24, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $55,000, for which $47,500 in proceeds were received on May 8, 2017. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of April 24, 2018. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $17,863 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature and the warrants as derivative liabilities, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. During the three and nine month periods ended September 30, 2018, the lender did not convert any principal, interest and fees into common shares and converted $47,613 of principal, interest and fees into 31,442,665 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.
 
$50,000 Secured Convertible Note – WBRE – Note 8
 
On June 26, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $50,000, for which $50,000 in proceeds were received on September 26, 2017. Under the terms of the agreement, the convertible note incurs interest at 12% per annum and matured on December 26, 2017. The convertible note has since been retired through a debt exchange agreement with a third party dated March 8, 2018, see "$60,000 Convertible Note" below.
 
$50,000 Convertible Note – Crown Bridge – Note 9
 
On July 19, 2017, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $50,000, for which $43,000 in proceeds were received on July 25, 2017. Under the terms of the agreement, the convertible note incurs interest at 5% per annum and has a maturity date of July 19, 2018. During the three and nine month ended September 30, 2018 the Company amortized $0 and $27,397 respectively to interest expense. As of September 30, 2018, a discount of $0 remained.
 
During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $54,697 of principal, interest and fees into 56,453,381 common shares respectively. As of September 30, 2018 there were 333,470,447 common shares reserved with our transfer agent. As of September 30, 2018 the Company had fulfilled all the obligations of the note.
 
$30,000 Convertible Note – Global – Note 14
 
On January 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $30,000, for which 12,500,000 outstanding warrants from the convertible note dated April 24, 2017 were extinguished. The difference between the convertible note, the conversion feature and the value of the warrants was recorded as a derivative loss. No proceeds were received in conjunction with this note. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of January 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of up to 0 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
The Company has the option to redeem the convertible notes at any time within 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.
 
During the three and nine month periods ended September 30, 2018, the lender converted $5,000 of principal, interest and fees into 816,994 common shares and $32,744 of principal, interest and fees into 5,350,345 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.
 
$44,000 Convertible Note – Adar Bays – Note 15
 
On January 17, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $44,000, for which $19,000 in proceeds were received on January 23, 2018 and $19,000 in proceeds were received on February 26, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of January 17, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing the on issuance discount of $4,000, legal fees of $2,000 and the remaining discount of $34,324 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $40,324 to interest expense using the straight-line method over the term of the loan. During the three and nine month periods ended September 30, 2018 the Company amortized $0 and $40,324 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
There is no option for the Company to redeem the convertible note prior to maturity.
 
During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $44,000 of principal, interest and fees into 27,518,485 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.
 
In connection with the original agreement, the holder had the option to fund three additional $44,000 back end convertible notes. On July 16, 2018, the holder exercised this option and entered into three separate $44,000 convertible notes totaling $132,000. For which the Company received a total of $114,000 in net proceeds. Under the terms of the agreements, the convertible notes incurred interest at 10% per annum and has a maturity date of January 17, 2019. The convertible note are convertible upon issuance at a fixed price of $0.025 per share. The Company is amortizing the on issuance discount of $18,000 and the remaining discount of $114,000 due to the recording of a beneficiation conversion feature. In July and August 2018, the convertible notes were converted into 5,280,000 shares of common stock. The Company amortized the entire discount of $132,000 to interest expense during the three and nine months ended September 30, 2018. As of September 30, 2018, a discount of $0 remained.
 
$12,500 Convertible Note – Global – Note 16
 
On January 22, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $12,500, in exchange for the release of reserved shares to the Company. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of January 22, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
The Company has the option to redeem the convertible note within 180 days from the date of issuance at 120% of the principal and interest. After 180 days the right of prepayment expires.
 
During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $12,925 of principal, interest and fees into 2,111,873 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.
 
$53,000 Convertible Note – PowerUp – Loan 17
 
On February 15, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $53,000, for which $50,000 in proceeds were received on February 22, 2018 . Under the terms of the agreement, the convertible note incurs interest at 12% per annum and has a maturity date of February 15, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 61% of the average of the two lowest traded prices of the Company’s common stock during the previous 15 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing the on issuance discount of $3,000 and the remaining discount of $50,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $53,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $0 and $53,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of up to 0 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 22%.
 
The Company has the option to redeem the convertible notes within 90 days from the date of issuance at 115% of the principal and interest; between 91 and to 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.
 
On April 26, 2018 the Company retired the note with a payment of $82,084 to the note holder. A derivative liability gain of $279,795 was recorded to reflect the retirement of the derivative liability.
 
$27,500 Convertible Note – Global – Note 18
 
On March 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $27,500, for which proceeds of $23,500 were received on March 9, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is amortizing the discount of $27,500 due to on issuance discount of $4,000 and the recording of a derivative liability as discussed in Note 5. The Company is amortizing the discount of $27,500 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $0 and $27,500 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
The Company has the option to redeem the convertible notes within 30 days from the date of issuance at 115% of the principal and interest; between 31 and to 60 days from the date of issuance at 120% of the principal and interest; between 61 and to 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 120 days from the date of issuance at 130% of the principal and interest; between 121 and to 150 days from the date of issuance at 135% of the principal and interest; between 151 and 180 days from issuance at 140% of principal and interest; and after 180 days the right of prepayment expires.
 
During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $28,344 of principal, interest and fees into 4,631,346 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.
 
$60,000 Convertible Note – Global – WBRE Exchange – Note 19
 
March 9, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $60,000, in exchange for the extinguishment of the outstanding principal due on the convertible note dated September 26, 2017, see disclosure above for "
$50,000 Secured Convertible Note".
No proceeds were received in conjunction with the exchange of this convertible note. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 9, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. At no additional cost, we issued to the note holder 30,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 120% of the principal and interest; and after 180 days the right of prepayment expires.
 
At the date of the agreement, the Company determined that the transactions qualified for extinguishment accounting whereby the transaction was accounted for at fair market value with the excess value between the fair value of the old note and new note was accounted for as an extinguishment loss of $154,284.
 
During the three and nine month periods ended September 30, 2018, the lender converted $0 of principal, interest and fees into 0 common shares and $60,147 of principal, interest and fees into 45,665,203 common shares respectively. As of September 30, 2018 the Company had fulfilled all the obligations of the note.
 
$115,000 Convertible Note – Auctus – Note 20
 
On March 13, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $115,000, for which $97,250 in proceeds were received on March 19, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of December 13, 2018. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the average of the two lowest traded prices of the Company’s common stock during the previous 25 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to six times the number of common shares the convertible note is convertible into. The Company is amortizing the original issuance discount of $15,000 legal fees of $2,750 and the remaining discount of $97,250 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $115,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month periods ended September 30, 2018 the Company amortized $69,418 and $115,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 34,737,400 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 125% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
The Company has the option to redeem the convertible notes within 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 180 days from the date of issuance at 140% of the principal and interest; and after 180 days the right of prepayment expires.
 
During the three and nine month periods ended September 30, 2018, the lender converted $43,769 of principal, interest and fees into 34,737,400 common shares. On August 8, 2018, the Company retired the note and accrued interest with a payment of $106,312 to the note holder, which included a prepayment fee of $30,128 recorded within interest expense.
 
$48,000 Convertible Note – GS – Note 21
 
On March 15, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $48,000, for which $45,600 in proceeds were received on March 20, 2018. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 15, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 63% of the average of the two lowest traded prices of the Company’s common stock during the previous 12 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to six times the number of common shares the convertible note is convertible into. The Company is amortizing legal fees of $2,400 and the remaining discount of $45,600 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $48,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $0 and $48,000 to interest expense respectively. As of September 30, 2018, a discount of $0 remained.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 0 shares reserved with our transfer agent with a potential of 0 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
The Company has the option to redeem the convertible notes within 60 days from the date of issuance at 110% of the principal and interest; between 61 and to 120 days from the date of issuance at 124% of the principal and interest; between 121 days and to 180 days from the date of issuance at 138%; and after 180 days the right of prepayment expires.
 
On April 25, 2018 the Company retired the note with a payment of $60,000 to the note holder. A derivative liability gain of $209,076 was recorded to reflect the retirement of the derivative liability.
 
$110,000 Convertible Note – Morningview – Note 22
 
On April 3, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $95,000 in proceeds were received on April 3, 2018 . Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 29, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to five times the number of common shares the convertible note is convertible into. The Company is amortizing legal fees of $2,652 and the remaining discount of $107,348 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and nine months ended September 30, 2018 the Company amortized $27,726 and $54,247 to interest expense respectively. As of September 30, 2018, a discount of $55,753 remained. At no additional cost, we issued to the note holder 11,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company accounted for the conversion feature as a derivative liability, see Note 5. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 84,110,033 shares reserved with our transfer agent with a potential of 44,055,213 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 18%.
 
The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 140% of the principal and interest. After 180 days the right of prepayment expires.
 
$110,000 Convertible Note – Fourth Man – Note 23
 
On April 11, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $100,000 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity 12 months from the effective date of payment. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $10,000 and the remaining discount of $100,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $27,726 and $51,836 to interest expense respectively. As of September 30, 2018, a discount of $58,164 remained. At no additional cost, we issued to the note holder 11,000,000 five-year warrants to purchase common stock at $0.01, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 18,333,333 shares reserved with our transfer agent with a potential of 26,377,915 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 18%.
 
The Company has the option to redeem the convertible notes within 180 days from the date of issuance at 140% of the principal and interest. After 180 days the right of prepayment expires.
 
$110,000 Convertible Note – Power Up – Note 24
 
On April 13, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $110,000, for which $99,000 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 10% per annum and has a maturity date of March 29, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $10,000, legal fees of $1,000 and the remaining discount of $99,000 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $110,000 to interest expense using the straight-line method over the term of the loan. During the three and months ended September 30, 2018 the Company amortized $27,726 and $51,836 to interest expense respectively. As of September 30, 2018, a discount of $58,164 remained.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 13,000,000 shares reserved with our transfer agent with a potential of 26,377,915 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 22%.
 
The Company has the option to redeem the convertible notes within 30 days from the date of issuance at 115% of the principal and interest; between 31 and to 60 days from the date of issuance at 120% of the principal and interest; between 61 and to 90 days from the date of issuance at 125% of the principal and interest; between 91 and to 120 days from the date of issuance at 130% of the principal and interest; between 121 and to 150 days from the date of issuance at 135% of the principal and interest; between 151 and to 180 days from the date of issuance at 140% of the principal and interest; and after 180 days the right of prepayment expires.
 
$108,000 Convertible Note – Global – Note 25
 
On May 14, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $108,000, for which $94,960 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of May 14, 2019. The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $8,000, legal fees of $5,040 and the remaining discount of $94,960 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $108,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $27,222 and $41,129 to interest expense. As of September 30, 2018, a discount of $66,871 remained. At no additional cost, we issued to the note holder 3,600,000 five-year warrants to purchase common stock at $0.025, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 35,000,000 shares reserved with our transfer agent with a potential of 25,486,329 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 150% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
There is no option to pre-pay this note.
 
$108,000 Note – Global – Note 26
 
On June 27, 2018, the Company entered into a note agreement with a third party for an aggregate principal amount of $108,000, for which $100,000 in proceeds were received. Under the terms of the agreement, the note incurs interest at 8% per annum and has a maturity date of September 27, 2019. The Company is amortizing the on-issuance discount of $8,000 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $1,797 and $1,863 and to interest expense respectively. On September 20, 2018, this note was combined with other notes disclosed below, a portion of which was repaid with the remainder being rolled into Global - Note 28 disclosed below. As of September 30, 2018, a discount of $0 remained.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
$108,000 Note – Global – Note 27
 
On August 8, 2018, the Company entered into a note agreement with a third party for an aggregate principal amount of $108,000, for which $106,500 in proceeds were received. Under the terms of the agreement, the note incurs interest at 8% per annum and has a maturity date of August 8, 2019. The Company is amortizing the on-issuance discount of $1,500 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $177 to interest expense. On September 20, 2018, this note was combined with other notes disclosed immediately above and below, a portion of which was repaid with the remainder being rolled into Global - Note 28 disclosed below. As of September 30, 2018, a discount of $0 remained.
 
In the event of default, the holder has the right to require the Company to pay an amount equal to 120% multiplied by the then outstanding entire balance of the note, including principal and accrued unpaid interest. In addition, the default interest rate would increase to 24%.
 
$183,250 Convertible Note – Global – Note 28
 
On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $100,000 in proceeds were received and remaining balances convertible notes disclosed above were rolled over. At the time of combination, the total carrying amount outstanding under the prior notes was $211,570. In connection, with the agreement, Global was paid $139,352, principal of $69,676 rolled into the new note and a gain of $2,542 was recorded within interest expense. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company’s stock at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574 and the remaining discount of $169,676 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.
 
The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.
 
$183,250 Convertible Note – Morningview – Note 29
 
On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $169,676 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company’s stock at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574, legal fees of $8,363 and the remaining discount of $161,313 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.
 
The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.
 
$183,250 Convertible Note – Fourth Man – Note 29
 
On September 20, 2018, the Company entered into a convertible note agreement with a third party for an aggregate principal amount of $183,250, for which $169,676 in proceeds were received. Under the terms of the agreement, the convertible note incurs interest at 8% per annum and has a maturity date of September 20, 2019. The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company’s stock at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date. The Company is required at all times to reserve shares of the Company’s common stock equal to three times the number of common shares the convertible note is convertible into. The Company is amortizing an on-issuance discount of $13,574, legal fees of $8,363 and the remaining discount of $161,313 due to the recording of a derivative liability as discussed in Note 5. The Company is amortizing the total discount of $183,250 to interest expense using the straight-line method over the term of the loan. During the three and nine month ended September 30, 2018 the Company amortized $5,021 to interest expense. As of September 30, 2018, a discount of $178,229 remained. At no additional cost, we issued to the note holder 1,247,618 five-year warrants to purchase common stock at $0.088, subject to adjustment if we issue securities at less than the exercise price.  The warrants are exercisable on a cashless basis.
 
The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below the conversion price of the convertible note. On the date of issuance, the Company anticipates that it will account for conversion feature as a derivative liability. Derivative accounting applies as the conversion price is variable and does not have a floor as to the number of common shares in which could be converted. Thus, if the convertible note is not repaid prior to the note being converted significant pressure maybe put on the Company’s stock price and additional dilution of current shareholders may take place. As of September 30, 2018, there were 25,000,000 shares reserved with our transfer agent with a potential of 38,859,058 being reserved if and when the lender issues a request to our transfer agent.
 
In the event of default that is either (A) demanded (if demand or notice is required to create an Event of Default), (B) otherwise due, or (C) paid in full, whichever is lowest, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 120% of the outstanding principal amount of this Note, plus, (b) all other amounts, costs, expenses and liquidated damages due in respect of the Note.
 
The Company has the option to redeem the note, in whole, up to 30 days from the date of issuance with no interest, on issuance discount, fees or pre-payment penalties. From 31 through 170 days, the Company has the option to redeem the note at the default amount stated above. After 170 days the right of prepayment expires.
 
As of September 30, 2018, future loan maturities are as follows:
 
For the year ended December 31,
 
 
 
 
 
 
 
2018
 
 
0
 
2019
 
 
987,750
 
Total
 
$
987,750
 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
DERIVATIVE LIABILITIES
9 Months Ended
Sep. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities Disclosure [Text Block]
NOTE 5 – DERIVATIVE LIABILITIES
 
Derivative Liabilities
 
In connection with convertible notes payable, the Company records derivative liabilities for the conversion feature. In addition, the Company has warrants for which the exercise prices reset upon future events. These warrants are also considered to be derivative liabilities. The derivative liabilities are valued on the date the convertible note payable become convertible and revalued at each reporting period. The warrants are valued on the date of issuance and revalued at each reporting period. During the nine months ended September 30, 2018, the Company recorded initial derivative liabilities of $3,205,183 based upon the following Black-Scholes option pricing model average assumptions: an exercise price of $0.0009 to $0.0137 our stock price on the date of grant of $0.0029 to $0.0550, expected dividend yield of 0%, expected volatility of 86% to 214%, risk free interest rate of 2.03% to 2.80% and expected terms ranging from 1.0 to 5.0 years. Upon initial valuation, the derivative liability exceeded the face value certain of the convertible note payables by approximately $2,671,002, which was recorded as a day one loss on derivative liability.
 
On September 30, 2018, the derivative liabilities were revalued at $6,818,117 resulting in a loss of $919,147 related to the change in fair market value of the derivative liabilities during the three months ended September 30, 2018. The total loss related to the change in fair market value of the derivative liabilities during the nine months ended September 30, 2018 was $11,640,425. The derivative liabilities were revalued using the Black-Scholes option pricing model with the following average assumptions: an exercise price of $0.0008 to $0.0880, our stock price on the date of valuation ($0.0234), expected dividend yield of 0%, expected volatility of 95% to 214%, risk-free interest rates ranging from 2.63 - 2.80%, and an expected terms ranging from 0.5 to 4.9 years.
 
In connection with convertible notes converted and warrants exercised, as disclosed in Note 5, the Company reclassed derivative liabilities with a fair value of $9,336,681 to additional paid-in capital. The Company revalued the derivative liabilities at each conversion date recording the pro-rata portion of the derivative liability as compared to the portion of the convertible note converted to the pre-conversion carrying value to additional paid-in capital
 
Future Potential Dilution
 
Most of the Company’s convertible notes payable contain adjustable conversion terms with significant discounts to market. As of September 30, 2018 the Company’s convertible notes payable are potentially convertible into an aggregate of approximately 74 million shares of common stock. In addition, due to the variable conversion prices on some of the Company’s convertible notes, the number of common shares issuable is dependent upon the traded price of the Company’s common stock.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
WARRANTS
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Shareholders' Equity and Share-based Payments [Text Block]
NOTE 6 – WARRANTS
 
The fair value of each warrant is estimated using the Black-Scholes valuation model. Assumptions used in calculating the fair value at September 30, 2018 were as follows:
 
 
 
Weighted

Average

Inputs Used
 
 
 
 
 
Annual dividend yield
 
$
-
 
Expected life (years)
 
 
3.8 to 4.9
 
Risk-free interest rate
 
 
2.63
%
Expected volatility
 
 
91
%
Common stock price
 
$
0.0234
 
 
Since the expected life of the options was greater than the Company’s historical stock information available, the Public Company determined the expected volatility based on price fluctuations of comparable public companies.
 
The issuances, exercises and pricing re-sets during the nine months ended September 30, 2018 are as follows:
          
Outstanding at December 31, 2017
 
 
23,426,087
 
Issuances
 
 
69,919,777
 
Exercises
 
 
(223,803,769
)
Anti-Dilution/Modification
 
 
401,430,751
 
Forfeitures/cancellations
 
 
(15,200,000
)
Outstanding at September 30, 2018
 
 
255,772,846
 
Weighted Average Price at September 30, 2018
 
$
0.0023
 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
NOTE
7 –SUBSEQUENT EVENTS
 
In accordance with ASC 855, management reviewed all material events through August 14, 2018, for these financial statements and there are no material subsequent events to report, except as follows:
 
Co
nversion Notice
 
From October 16, 2018 through October 22, 2018 we issued
11,967,158
shares of common stock for the conversion 
of $115,000
in convertible notes
.
 
On October 18, 2018 we issued 9,297,576 shares of common stock to a lender whom exercised 10,000,000 warrants in a cashless exercise. 
 
On November 12, 2018 we issued
25,055,575
shares of common stock to a lender whom exercised
28,200,000
warrants in a cashless exercise
.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
– The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
– The accompanying unaudited condensed consolidated financial statements have been prepared without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2018 and for the three and nine month periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. The operations for the three and nine month periods ended September 30, 2018, are not necessarily indicative of the operating results for the full year.
Liquidity Policy [Policy Text Block]
Going Concern
– The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, during the nine month period ended September 30, 2018, the Company incurred a net loss of $15,590,004 had negative cash flows from operating activities, had a working capital deficit of $7,522,727 and had minimal revenue-generating activities. These factors raise substantial doubt about the ability of the Company to continue as a going concern. In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of equity securities. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.
Revenue Recognition, Policy [Policy Text Block]
Revenue
- The Company recognizes revenue as it is earned as defined by U.S. GAAP. We have adopted the new revenue recognition standard ASC 606 that went into effect on January 1, 2018 and determined there was no material impact to the Company’s financial statements. All revenues reported in 2018 and beyond will reflect those standards.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments 
 
 - The Company’s financial instruments consist of cash and cash equivalents, convertible notes, and payables.  The carrying amount of cash and cash equivalents and payables approximates fair value because of the short-term nature of these items.
 
When determining fair value, whenever possible the Company uses observable market data, and relies on unobservable inputs only when observable market data is not available. As of September 30, 2018 and December 31, 2017, the Company didn’t have any Level 1 or 2 financial instruments. The table below reflects the results of our Level 3 fair value calculations:
 
 
 
Notes
 
 
Warrants
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
Derivative liability at December 31, 2017
 
$
1,060,315
 
 
$
248,875
 
 
$
1,309,190
 
Addition of new conversion option derivatives
 
 
2,839,915
 
 
 
365,268
 
 
 
3,205,183
 
Conversion of note derivatives
 
 
(4,739,284
)
 
 
(4,597,397
)
 
 
(9,336,681
)
Change in fair value
 
 
1,948,816
 
 
 
9,691,609
 
 
 
11,640,425
 
Derivative liability at September 30, 2018
 
$
1,109,762
 
 
$
5,708,355
 
 
$
6,818,117
 
Earnings Per Share, Policy [Policy Text Block]
Basic and Diluted Loss Per Share –
The Company follows Financial Accounting Standards Board (“FASB”) ASC 260 Earnings per Share to account for earnings per share. Basic earnings per share (“EPS”) calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. During the three and nine month periods ended September 30, 2018, the Company had 500,000 options and 255,771,846 warrants to purchase common stock outstanding. During the three and nine month periods ended September 30, 2017, the Company had 500,000 options and 966,667 warrants to purchase common stock outstanding. In addition, the Company has various convertible notes payable which at September 30, 2018 are convertible into approximately 73,750,820 shares of common stock. The effects of the dilutive securities were anti-dilutive due to net loss during the three and nine month periods 
ended September 30, 2018 and 2017.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements –
In July 2017, the FASB issued ASU No. 2017-11, “Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 815),” which addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.
 
The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements other than disclosed above.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
 
 
Notes
 
 
Warrants
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
Derivative liability at December 31, 2017
 
$
1,060,315
 
 
$
248,875
 
 
$
1,309,190
 
Addition of new conversion option derivatives
 
 
2,839,915
 
 
 
365,268
 
 
 
3,205,183
 
Conversion of note derivatives
 
 
(4,739,284
)
 
 
(4,597,397
)
 
 
(9,336,681
)
Change in fair value
 
 
1,948,816
 
 
 
9,691,609
 
 
 
11,640,425
 
Derivative liability at September 30, 2018
 
$
1,109,762
 
 
$
5,708,355
 
 
$
6,818,117
 
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
DEBT (Tables)
9 Months Ended
Sep. 30, 2018
Debt Disclosure [Abstract]  
Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]
As of September 30, 2018, future loan maturities are as follows:
 
For the year ended December 31,
 
 
 
 
 
 
 
2018
 
 
0
 
2019
 
 
987,750
 
Total
 
$
987,750
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
WARRANTS (Tables)
9 Months Ended
Sep. 30, 2018
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The fair value of each warrant is estimated using the Black-Scholes valuation model. Assumptions used in calculating the fair value at September 30, 2018 were as follows:
 
 
 
Weighted

Average

Inputs Used
 
 
 
 
 
Annual dividend yield
 
$
-
 
Expected life (years)
 
 
3.8 to 4.9
 
Risk-free interest rate
 
 
2.63
%
Expected volatility
 
 
91
%
Common stock price
 
$
0.0234
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
The issuances, exercises and pricing re-sets during the nine months ended September 30, 2018 are as follows:
          
Outstanding at December 31, 2017
 
 
23,426,087
 
Issuances
 
 
69,919,777
 
Exercises
 
 
(223,803,769
)
Anti-Dilution/Modification
 
 
401,430,751
 
Forfeitures/cancellations
 
 
(15,200,000
)
Outstanding at September 30, 2018
 
 
255,772,846
 
Weighted Average Price at September 30, 2018
 
$
0.0023
 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
9 Months Ended
Sep. 30, 2018
USD ($)
Derivative liability at December 31, 2017 $ 1,309,190
Addition of new conversion option derivatives 3,205,183
Conversion of note derivatives (9,336,681)
Change in fair value 11,640,425
Derivative liability at September 30, 2018 6,818,117
Notes [Member]  
Derivative liability at December 31, 2017 1,060,315
Addition of new conversion option derivatives 2,839,915
Conversion of note derivatives (4,739,284)
Change in fair value 1,948,816
Derivative liability at September 30, 2018 1,109,762
Warrants [Member]  
Derivative liability at December 31, 2017 248,875
Addition of new conversion option derivatives 365,268
Conversion of note derivatives (4,597,397)
Change in fair value 9,691,609
Derivative liability at September 30, 2018 $ 5,708,355
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Working Capital Deficit $ 7,522,727   $ 7,522,727  
Conversion of Stock, Shares Issued     73,750,820  
Net loss $ (1,571,020) $ (52,182) $ (15,590,004) $ (1,181,889)
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 255,171,846 966,667 255,771,846 966,667
Employee Stock Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 500,000 500,000 500,000 500,000
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
LICENSING AGREEMENTS (Details Textual) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
May 17, 2017
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Amortization of Intangible Assets   $ 5,286 $ 5,286 $ 15,858 $ 10,709  
Finite-Lived Intangible Assets, Net   168,791   168,791   $ 184,649
Maximum [Member]            
Long-term Purchase Commitment, Amount $ 2,500,000          
Initiation Of Clinical Trial [Member]            
Long-term Purchase Commitment, Amount 100,000          
Completion Of Clinical Trial [Member]            
Long-term Purchase Commitment, Amount 200,000          
Filing For IND With FDA [Member]            
Long-term Purchase Commitment, Amount 100,000          
Closing Of First Patient In Phase 1-2 Clinical Trial [Member]            
Long-term Purchase Commitment, Amount 200,000          
Closing Of First Patient In Phase 3 Clinical Trial [Member]            
Long-term Purchase Commitment, Amount $ 400,000          
Patents [Member]            
Finite-Lived Intangible Assets, Net   73,397   73,397    
Finite Lived Intangible Assets, Expected Annual Amortization       $ 9,972    
Licensing Agreements [Member]            
Royalty Payment Percentage       6.00%    
Non-Royalty Sublease Income Percentage       25.00%    
Payments for Royalties       $ 20,000   $ 50,000
Finite-Lived Intangible Assets, Net   7,894   7,894    
Finite Lived Intangible Assets, Expected Annual Amortization       1,172    
Multipotent Amniotic Fetal Stem Cells License Agreement [Member] | Patents [Member]            
Amortization of Intangible Assets   293   879    
Creative Medical Health, Inc [Member] | Patents [Member]            
Amortization of Intangible Assets   2,493   $ 7,479    
StemSpine, Llc [Member]            
Royalty Payment Percentage 5.00%          
Non-Royalty Sublease Income Percentage 50.00%          
StemSpine, Llc [Member] | Patents [Member]            
Finite-Lived Intangible Asset, Expiration Period       2027    
Amortization of Intangible Assets   2,500   $ 7,500    
Payments to Acquire Intangible Assets $ 100,000          
Finite-Lived Intangible Assets, Net   $ 87,500   87,500    
Finite Lived Intangible Assets, Expected Annual Amortization       $ 10,000    
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Apr. 11, 2018
Jan. 12, 2018
May 04, 2017
Aug. 31, 2018
Nov. 17, 2017
Jul. 31, 2017
Sep. 30, 2018
Dec. 31, 2016
Sep. 20, 2018
Dec. 31, 2017
Related Party Transaction [Line Items]                    
Management Fee Payable             $ 269,050     $ 352,750
Reimbursement of Management Fees             $ 35,000      
Management Reimbursement Agreement description         At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days’ prior written notice.<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>          
Debt Conversion, Converted Instrument, Shares Issued       5,280,000     74,000,000      
Debt Instrument, Interest Rate, Stated Percentage                 8.00%  
Series A Preferred Stock [Member] | Timothy Warbington [Member]                    
Related Party Transaction [Line Items]                    
Debt Conversion, Original Debt, Amount   $ 150,000                
Debt Conversion, Converted Instrument, Shares Issued   3,000,000                
Common Stock [Member]                    
Related Party Transaction [Line Items]                    
Debt Conversion, Converted Instrument, Shares Issued 9,855,307                  
Creative Medical Health [Member]                    
Related Party Transaction [Line Items]                    
Management Fee Payable             $ 269,050      
Reimbursement of Management Fees             35,000      
Minimum Amount To Be Raised Through Equity Issuance             $ 1,000,000      
Common Stock Discount On Shares Percentage         30.00%          
Debt Instrument, Interest Rate, Stated Percentage               8.00%    
Creative Medical Health [Member] | Series A Preferred Stock [Member]                    
Related Party Transaction [Line Items]                    
Debt Conversion, Original Debt, Amount   $ 150,000                
Debt Conversion, Converted Instrument, Shares Issued   3,000,000                
Creative Medical Health [Member] | February Note [Member]                    
Related Party Transaction [Line Items]                    
Proceeds from Lines of Credit               $ 50,000    
Line of Credit Facility, Initiation Date     Apr. 30, 2017         Feb. 02, 2016    
Line of Credit Facility, Maximum Borrowing Capacity     $ 50,000         $ 50,000    
Line of Credit Facility, Expiration Date     Apr. 30, 2018         Apr. 30, 2018    
Line of Credit Facility, Interest Rate During Period     8.00%              
Interest Payable, Current     $ 4,050              
Creative Medical Health [Member] | May Note One [Member]                    
Related Party Transaction [Line Items]                    
Proceeds from Lines of Credit               $ 50,000    
Line of Credit Facility, Initiation Date           Jul. 31, 2017   May 01, 2016    
Line of Credit Facility, Maximum Borrowing Capacity           $ 50,000   $ 50,000    
Line of Credit Facility, Expiration Date           Jul. 31, 2018   Jul. 31, 2018    
Line of Credit Facility, Interest Rate During Period           8.00%        
Interest Payable, Current           $ 4,050        
Creative Medical Health [Member] | May Note Two [Member]                    
Related Party Transaction [Line Items]                    
Proceeds from Lines of Credit               $ 25,000    
Line of Credit Facility, Initiation Date               May 18, 2016    
Line of Credit Facility, Maximum Borrowing Capacity               $ 25,000    
Line of Credit Facility, Expiration Date               May 18, 2018    
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
DEBT (Details)
Sep. 30, 2018
USD ($)
2018 $ 0
2019 987,750
Total $ 987,750
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
DEBT (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 08, 2018
May 14, 2018
Apr. 13, 2018
Apr. 11, 2018
Apr. 03, 2018
Mar. 15, 2018
Mar. 09, 2018
Jan. 09, 2018
Apr. 10, 2017
Sep. 30, 2018
Sep. 20, 2018
Aug. 31, 2018
Jul. 16, 2018
Jun. 27, 2018
Apr. 26, 2018
Apr. 25, 2018
Mar. 23, 2018
Mar. 13, 2018
Feb. 15, 2018
Jan. 23, 2018
Jan. 22, 2018
Jan. 17, 2018
Jul. 25, 2017
Jul. 19, 2017
Jun. 26, 2017
May 02, 2017
Apr. 24, 2017
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Debt Conversion, Converted Instrument, Shares Issued                       5,280,000                                   74,000,000  
Proceeds from Issuance of Long-term Debt $ 106,500                                                            
Debt Instrument, Face Amount 108,000                                                            
Debt Instrument, Interest Rate, Stated Percentage                     8.00%                                        
Amortization of Debt Discount (Premium)                   $ 0                                       $ 878,349 $ 173,578
Debt Instrument, Maturity Date                     Sep. 20, 2019   Jan. 17, 2019                                    
Proceeds from Convertible Debt                                                           1,378,072 376,250
Legal Fees     $ 1,000               $ 8,363                     $ 2,000                  
Debt Instrument, Unamortized Discount                                           40,324                  
Amortization of Debt Issuance Costs                                                           1,863  
Redeemable Convertible Debenture Principal And Interest Percentage         150.00%                                                    
Default Interest Rate         18.00%                                                    
Gain (Loss) on Extinguishment of Debt                     69,676                                 $ 0 $ 0 496,645 0
Derivative, Gain (Loss) on Derivative, Net                                                           2,671,002  
Debt Conversion, Converted Instrument, Amount                                                           $ 10,319,680 $ 0
Debt Instrument, Convertible, Beneficial Conversion Feature                         $ 114,000                                    
Interest Expense, Debt                     2,542                                        
Debt Instrument, Fee Amount 30,128                                                            
Maximum [Member]                                                              
Share Price                   $ 0.0550                                   $ 0.0550   $ 0.0550  
Redeemable Convertible Debentures, Maturity Period,Within 90 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage                                   125.00% 115.00%                        
Redeemable Convertible Debentures,Maturity Period ,Between 91 and 120 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage     130.00%                                                        
Redeemable Convertible Debentures,Maturity Period,Between 121 and 150 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage     135.00%                                                        
Redeemable Convertible Debentures,Maturity Period,After 180 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage             120.00% 120.00%                         120.00%                    
Redeemable Convertible Debentures,Maturity Period ,Between 91 and 180 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage                                   140.00% 120.00%                        
Redeemable Convertible Debentures, Maturity Period,Within 30 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage     115.00%                                                        
Redeemable Convertible Debentures,Maturity Period ,Between 31 and 60 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage     120.00%                                                        
Redeemable Convertible Debentures,Maturity Period ,Between 61 and 90 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage     125.00%                                                        
Redeemable Convertible Debentures,Maturity Period ,Between 121 and 180 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage           138.00%                                                  
Redeemable Convertible Debentures Maturity Period Between 61 And 120 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage           124.00%                                                  
Redeemable Convertible Debentures Maturity Period Within 60 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage           110.00%                                                  
Redeemable Convertible Debentures, Maturity Period,Within 180 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage       140.00% 140.00%                                                    
Convertible Debt 400000 [Member]                                                              
Debt Conversion, Original Debt, Amount                                                       $ 0   $ 54,200  
Debt Conversion, Converted Instrument, Shares Issued                                                       0   23,485,183  
Proceeds from Issuance of Long-term Debt                                                   $ 360,000          
Debt Instrument, Face Amount                                                   400,000          
Amortization of Debt Discount (Premium)                                                           $ 0  
Amortization of Debt Issuance Costs                                                       $ 0   54,085  
Payment for Debt Extinguishment or Debt Prepayment Cost                                 $ 1,000                            
Convertible Debt 115000 [Member]                                                              
Debt Conversion, Original Debt, Amount                                                           $ 134,127  
Debt Conversion, Converted Instrument, Shares Issued                                                           145,929,641  
Proceeds from Issuance of Long-term Debt                 $ 103,250                 $ 97,250                          
Debt Instrument, Face Amount                 $ 115,000                 $ 115,000                          
Debt Instrument, Interest Rate, Stated Percentage                 10.00%                 10.00%                          
Amortization of Debt Discount (Premium)                                   $ 15,000                       $ 0  
Debt Instrument, Maturity Date                 Jan. 10, 2018                 Dec. 13, 2018                          
Legal Fees                                   $ 2,750                          
Debt Instrument, Unamortized Discount                                   $ 115,000                          
Amortization of Debt Issuance Costs                                                       $ 0   $ 4,600  
Redeemable Convertible Debenture Principal And Interest Percentage                                   125.00%                          
Common Stock, Capital Shares Reserved for Future Issuance                   34,737,400                                   34,737,400   34,737,400  
Default Interest Rate                                   24.00%                          
Convertible Debt 115000 [Member] | Maximum [Member]                                                              
Amortization of Debt Discount (Premium)                                   $ 97,250                          
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Convertible Debt 55000 [Member]                                                              
Debt Conversion, Original Debt, Amount                                                           $ 47,613  
Debt Conversion, Converted Instrument, Shares Issued                                                           31,442,665  
Proceeds from Issuance of Long-term Debt                                                     $ 47,500        
Debt Instrument, Face Amount                                                     $ 55,000        
Debt Instrument, Interest Rate, Stated Percentage                                                     10.00%        
Amortization of Debt Discount (Premium)                                                           $ 0  
Debt Instrument, Maturity Date                                                     Apr. 24, 2018        
Amortization of Debt Issuance Costs                                                       $ 0   17,863  
Secured Convertible Note 50000 [Member]                                                              
Proceeds from Issuance of Long-term Debt                                                 $ 50,000            
Debt Instrument, Face Amount                   $ 54,697                             $ 50,000     54,697   54,697  
Debt Instrument, Interest Rate, Stated Percentage                                                 12.00%            
Debt Instrument, Maturity Date                                                 Dec. 26, 2017            
Convertible Note 50000 One [Member]                                                              
Debt Instrument, Face Amount                                                 $ 60,000            
Convertible Debt 30000 [Member]                                                              
Debt Conversion, Original Debt, Amount                                                       $ 5,000   $ 32,744  
Debt Conversion, Converted Instrument, Shares Issued                                                       816,994   5,350,345  
Proceeds from Issuance of Long-term Debt               $ 12,500,000                                              
Debt Instrument, Face Amount               $ 30,000                                              
Debt Instrument, Interest Rate, Stated Percentage               8.00%                                              
Debt Instrument, Maturity Date               Jan. 09, 2019                                              
Debt Instrument, Convertible, Terms of Conversion Feature               The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                                              
Redeemable Convertible Debenture Principal And Interest Percentage               120.00%                                              
Default Interest Rate               24.00%                                              
Convertible Debt 12500 [Member]                                                              
Debt Conversion, Original Debt, Amount                                                       $ 0   $ 12,925  
Debt Conversion, Converted Instrument, Shares Issued                                                       0   2,111,873  
Debt Instrument, Face Amount                                         $ 12,500                    
Debt Instrument, Interest Rate, Stated Percentage                                         8.00%                    
Debt Instrument, Maturity Date                                         Jan. 22, 2019                    
Debt Instrument, Convertible, Terms of Conversion Feature                                         The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                    
Redeemable Convertible Debenture Principal And Interest Percentage                                         120.00%                    
Default Interest Rate                                         24.00%                    
Convertible Debt 53000 [Member]                                                              
Proceeds from Issuance of Long-term Debt                                     $ 50,000                        
Debt Instrument, Face Amount                                     $ 53,000                        
Debt Instrument, Interest Rate, Stated Percentage                                     12.00%                        
Amortization of Debt Discount (Premium)                                     $ 3,000                     $ 0  
Debt Instrument, Maturity Date                                     Feb. 15, 2019                        
Debt Instrument, Unamortized Discount                                     $ 53,000                        
Amortization of Debt Issuance Costs                                                       $ 0   $ 53,000  
Redeemable Convertible Debenture Principal And Interest Percentage                                     120.00%                        
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Default Interest Rate                                     22.00%                        
Debt Instrument, Fair Value Disclosure                             $ 82,084                                
Derivative, Gain (Loss) on Derivative, Net                             $ 279,795                                
Convertible Debt 53000 [Member] | Maximum [Member]                                                              
Amortization of Debt Discount (Premium)                                     $ 50,000                        
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Convertible Debt 48000 [Member]                                                              
Proceeds from Issuance of Long-term Debt           $ 45,600                                                  
Debt Instrument, Face Amount           $ 48,000                                                  
Debt Instrument, Interest Rate, Stated Percentage           10.00%                                                  
Amortization of Debt Discount (Premium)           $ 45,600                                               $ 0  
Debt Instrument, Maturity Date           Mar. 15, 2019                                                  
Legal Fees           $ 2,400                                                  
Debt Instrument, Unamortized Discount           $ 48,000                                                  
Amortization of Debt Issuance Costs                                                       $ 0   $ 48,000  
Redeemable Convertible Debenture Principal And Interest Percentage           120.00%                                                  
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Default Interest Rate           24.00%                                                  
Debt Instrument, Fair Value Disclosure                               $ 60,000                              
Derivative, Gain (Loss) on Derivative, Net                               $ 209,076                              
Convertible Debt 48000 [Member] | Maximum [Member]                                                              
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Convertible Secured Debt 50,000 [Member]                                                              
Debt Conversion, Original Debt, Amount                                                       $ 0      
Debt Conversion, Converted Instrument, Shares Issued                                                       0   56,453,381  
Proceeds from Issuance of Long-term Debt                                             $ 43,000                
Debt Instrument, Face Amount                                               $ 50,000              
Debt Instrument, Interest Rate, Stated Percentage                                               5.00%              
Amortization of Debt Discount (Premium)                                                           $ 0  
Debt Instrument, Maturity Date                                               Jul. 19, 2018              
Amortization of Debt Issuance Costs                                                       $ 0   $ 27,397  
Treasury Stock, Shares                   333,470,447                                   333,470,447   333,470,447  
Convertible Debt 44000 [Member]                                                              
Debt Conversion, Original Debt, Amount                         132,000                             $ 0   $ 44,000  
Debt Conversion, Converted Instrument, Shares Issued                                                       0   27,518,485  
Proceeds from Issuance of Long-term Debt                         114,000             $ 19,000   19,000                  
Debt Instrument, Face Amount                         $ 132,000                 $ 44,000                  
Debt Instrument, Interest Rate, Stated Percentage                         10.00%                 10.00%                  
Amortization of Debt Discount (Premium)                         $ 18,000                 $ 4,000               $ 0  
Debt Instrument, Maturity Date                                           Jan. 17, 2019                  
Debt Instrument, Convertible, Terms of Conversion Feature                                           The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                  
Amortization of Debt Issuance Costs                                                       $ 0   $ 40,324  
Redeemable Convertible Debenture Principal And Interest Percentage                                           120.00%                  
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Default Interest Rate                                           24.00%                  
Debt Instrument, Convertible, Conversion Price                         $ 0.025                                    
Convertible Debt 44000 [Member] | Maximum [Member]                                                              
Amortization of Debt Discount (Premium)                                           $ 34,324                  
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Convertible Debt 27500 [Member]                                                              
Debt Conversion, Original Debt, Amount                                                       $ 0   $ 28,344  
Debt Conversion, Converted Instrument, Shares Issued                                                       0   4,631,346  
Proceeds from Issuance of Long-term Debt             $ 23,500                                                
Debt Instrument, Face Amount             $ 27,500                                                
Debt Instrument, Interest Rate, Stated Percentage             10.00%                                                
Amortization of Debt Discount (Premium)             $ 27,500                                             $ 0  
Debt Instrument, Maturity Date             Mar. 09, 2019                                                
Debt Instrument, Convertible, Terms of Conversion Feature             The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                                                
Debt Instrument, Unamortized Discount             $ 27,500                                                
Amortization of Debt Issuance Costs                                                       $ 0   27,500  
Redeemable Convertible Debenture Principal And Interest Percentage             150.00%                                                
Default Interest Rate             24.00%                                                
Convertible Debt 27500 [Member] | Maximum [Member]                                                              
Amortization of Debt Discount (Premium)             $ 4,000                                                
Convertible Debt 27500 [Member] | Redeemable Convertible Debentures,Maturity Period ,Between 91 and 120 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage             130.00%                                                
Convertible Debt 27500 [Member] | Redeemable Convertible Debentures,Maturity Period,Between 121 and 150 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage             135.00%                                                
Convertible Debt 27500 [Member] | Redeemable Convertible Debentures, Maturity Period,Within 30 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage             115.00%                                                
Convertible Debt 27500 [Member] | Redeemable Convertible Debentures,Maturity Period ,Between 31 and 60 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage             120.00%                                                
Convertible Debt 27500 [Member] | Redeemable Convertible Debentures,Maturity Period ,Between 61 and 90 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage             125.00%                                                
Convertible Debt 27500 [Member] | Redeemable Convertible Debentures,Maturity Period,Between 151 and 180 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage             140.00%                                                
Convertible Debt 60000 [Member]                                                              
Debt Conversion, Original Debt, Amount                                                       $ 0   $ 0  
Debt Conversion, Converted Instrument, Shares Issued                                                       60,147   45,665,203  
Debt Instrument, Face Amount             $ 60,000                                                
Debt Instrument, Interest Rate, Stated Percentage             10.00%                                                
Debt Instrument, Maturity Date             Mar. 09, 2019                                                
Debt Instrument, Convertible, Terms of Conversion Feature             The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                                                
Share Price             $ 0.01                                                
Number Of Warrants Issued             30,000,000                                                
Redeemable Convertible Debenture Principal And Interest Percentage             150.00%                                                
Default Interest Rate             24.00%                                                
Gain (Loss) on Extinguishment of Debt             $ 154,284                                                
Convertible Note 30000 - Global [Member]                                                              
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Convertible Note 30000 - Global [Member] | Maximum [Member]                                                              
Common Stock, Capital Shares Reserved for Future Issuance                   0                                   0   0  
Convertible Debt 110000 [Member]                                                              
Proceeds from Issuance of Long-term Debt         $ 95,000                                                    
Debt Instrument, Face Amount         $ 110,000                                                    
Debt Instrument, Interest Rate, Stated Percentage         10.00%                                                    
Amortization of Debt Discount (Premium)         $ 107,348                                                 $ 55,753  
Debt Instrument, Maturity Date         Mar. 29, 2019                                                    
Debt Instrument, Convertible, Terms of Conversion Feature         The convertible note is convertible upon issuance and convertible into shares of the Company’s stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                                                    
Legal Fees         $ 2,652                                                    
Debt Instrument, Unamortized Discount         $ 110,000                                                    
Amortization of Debt Issuance Costs                                                       $ 27,726   $ 54,247  
Share Price                   $ 0.01                                   $ 0.01   $ 0.01  
Number Of Warrants Issued                                                           11,000,000  
Common Stock, Capital Shares Reserved for Future Issuance                   84,110,033                                   84,110,033   84,110,033  
Convertible Debt 110000 [Member] | Maximum [Member]                                                              
Common Stock, Capital Shares Reserved for Future Issuance                   44,055,213                                   44,055,213   44,055,213  
Convertible Debt 110000 Fourth Man [Member]                                                              
Proceeds from Issuance of Long-term Debt       $ 100,000                                                   $ 100,000  
Debt Instrument, Face Amount       $ 110,000                                                      
Debt Instrument, Interest Rate, Stated Percentage       10.00%                                                      
Amortization of Debt Discount (Premium)                                                           58,164  
Debt Instrument, Convertible, Terms of Conversion Feature       conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                                                      
Legal Fees       $ 10,000                                                      
Debt Instrument, Unamortized Discount       $ 110,000                                                      
Amortization of Debt Issuance Costs                                                       $ 27,726   $ 51,836  
Share Price                   $ 0.01                                   $ 0.01   $ 0.01  
Number Of Warrants Issued                                                           11,000,000  
Redeemable Convertible Debenture Principal And Interest Percentage       150.00%                                                      
Common Stock, Capital Shares Reserved for Future Issuance                   18,333,333                                   18,333,333   18,333,333  
Default Interest Rate       18.00%                                                      
Convertible Debt 110000 Fourth Man [Member] | Maximum [Member]                                                              
Common Stock, Capital Shares Reserved for Future Issuance                   26,377,915                                   26,377,915   26,377,915  
Convertible Debt 110000 Powerup [Member]                                                              
Proceeds from Issuance of Long-term Debt     $ 99,000                                                        
Debt Instrument, Face Amount     $ 110,000                                                        
Debt Instrument, Interest Rate, Stated Percentage     10.00%                                                        
Amortization of Debt Discount (Premium)     $ 10,000                                                     $ 58,164  
Debt Instrument, Convertible, Terms of Conversion Feature     conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                                                        
Debt Instrument, Unamortized Discount     $ 110,000                                                        
Amortization of Debt Issuance Costs                                                       $ 27,726   $ 51,836  
Redeemable Convertible Debenture Principal And Interest Percentage     150.00%                                                        
Common Stock, Capital Shares Reserved for Future Issuance                   13,000,000                                   13,000,000   13,000,000  
Default Interest Rate     22.00%                                                        
Convertible Debt 110000 Powerup [Member] | Maximum [Member]                                                              
Amortization of Debt Discount (Premium)     $ 99,000                                                        
Common Stock, Capital Shares Reserved for Future Issuance                   26,377,915                                   26,377,915   26,377,915  
Convertible Debt 110000 Powerup [Member] | Redeemable Convertible Debentures,Maturity Period,Between 151 and 180 Days [Member]                                                              
Redeemable Convertible Debenture Principal And Interest Percentage     140.00%                                                        
Convertible Debt 108000 [Member]                                                              
Proceeds from Issuance of Long-term Debt   $ 94,960                                                          
Debt Instrument, Face Amount   $ 108,000                                                          
Debt Instrument, Interest Rate, Stated Percentage   8.00%                                                          
Amortization of Debt Discount (Premium)   $ 94,960                                                          
Debt Instrument, Maturity Date   May 14, 2019                                                          
Legal Fees   $ 5,040                                                          
Redeemable Convertible Debenture Principal And Interest Percentage   150.00%                                                          
Default Interest Rate   24.00%                                                          
Convertible Debt 108000 Global [Member]                                                              
Proceeds from Issuance of Long-term Debt                           $ 100,000                                  
Debt Instrument, Face Amount                           $ 108,000                                  
Debt Instrument, Interest Rate, Stated Percentage                           8.00%                                  
Amortization of Debt Discount (Premium)                                                           $ 66,871  
Debt Instrument, Maturity Date                           Sep. 27, 2019                                  
Debt Instrument, Convertible, Terms of Conversion Feature   conversion price equal to 60% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                                                          
Debt Instrument, Unamortized Discount   $ 108,000                       $ 8,000                                  
Amortization of Debt Issuance Costs   $ 8,000                                                   $ 27,222   $ 41,129  
Treasury Stock, Shares                   35,000,000                                   35,000,000   35,000,000  
Share Price   $ 0.025                                                          
Number Of Warrants Issued   3,600,000                                                          
Redeemable Convertible Debenture Principal And Interest Percentage                           120.00%                                  
Default Interest Rate                           24.00%                                  
Convertible Debt 108000 Global [Member] | Maximum [Member]                                                              
Common Stock, Capital Shares Reserved for Future Issuance                   25,486,329                                   25,486,329   25,486,329  
Convertible Debt 183250 Fourth Man [Member]                                                              
Proceeds from Issuance of Long-term Debt                     169,676                                        
Debt Instrument, Face Amount                     183,250                                        
Amortization of Debt Discount (Premium)                     13,574                                     $ 178,229  
Legal Fees                     8,363                                        
Debt Instrument, Unamortized Discount                     $ 183,250                                        
Amortization of Debt Issuance Costs                                                       $ 5,021   $ 5,021  
Share Price                     $ 0.088                                        
Number Of Warrants Issued                     1,247,618                                        
Common Stock, Capital Shares Reserved for Future Issuance                   25,000,000                                   25,000,000   25,000,000  
Convertible Debt 183250 Fourth Man [Member] | Maximum [Member]                                                              
Amortization of Debt Discount (Premium)                     $ 161,313                                        
Common Stock, Capital Shares Reserved for Future Issuance                   38,859,058                                   38,859,058   38,859,058  
Convertible Note 183250 Morningview [Member]                                                              
Proceeds from Issuance of Long-term Debt                     169,676                                        
Debt Instrument, Face Amount                     183,250                                        
Amortization of Debt Discount (Premium)                     13,574                                     $ 178,229  
Debt Instrument, Unamortized Discount                     $ 183,250                                        
Amortization of Debt Issuance Costs                                                       $ 5,021   $ 5,021  
Share Price                     $ 0.088                                        
Number Of Warrants Issued                     1,247,618                                        
Common Stock, Capital Shares Reserved for Future Issuance                   25,000,000                                   25,000,000   25,000,000  
Convertible Note 183250 Morningview [Member] | Maximum [Member]                                                              
Amortization of Debt Discount (Premium)                     $ 161,313                                        
Common Stock, Capital Shares Reserved for Future Issuance                   38,859,058                                   38,859,058   38,859,058  
Convertible Note 183250 Global [Member]                                                              
Debt Conversion, Original Debt, Amount                     139,352                                        
Proceeds from Issuance of Long-term Debt                     100,000                                        
Debt Instrument, Face Amount                     183,250                                        
Amortization of Debt Discount (Premium)                     $ 13,574                                     $ 178,229  
Debt Instrument, Convertible, Terms of Conversion Feature                     The convertible note is convertible at any time after 31 days after the closing date and convertible into shares of the Company’s stock at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the previous 20 trading days preceding the conversion date.                                        
Debt Instrument, Unamortized Discount                     $ 183,250                                        
Amortization of Debt Issuance Costs                                                       $ 5,021   $ 5,021  
Share Price                     $ 0.088                                        
Number Of Warrants Issued                     1,247,618                                        
Common Stock, Capital Shares Reserved for Future Issuance                   25,000,000                                   25,000,000   25,000,000  
Carrying Amount of Prior Notes                     $ 211,570                                        
Convertible Note 183250 Global [Member] | Maximum [Member]                                                              
Amortization of Debt Discount (Premium)                     $ 169,676                                        
Common Stock, Capital Shares Reserved for Future Issuance                   38,859,058                                   38,859,058   38,859,058  
Convertible Note 108000 Global [Member]                                                              
Amortization of Debt Discount (Premium)                                                           $ 0  
Amortization of Debt Issuance Costs                                                       $ 1,797      
Convertible Note 108000 Global 2 [Member]                                                              
Amortization of Debt Discount (Premium) $ 1,500                                                         0  
Amortization of Debt Issuance Costs                                                       177   177  
Redeemable Convertible Debenture Principal And Interest Percentage 120.00%                                                            
Default Interest Rate 24.00%                                                            
Convertible Note - Auctus [Member]                                                              
Debt Conversion, Original Debt, Amount                                                       $ 43,769   $ 43,769  
Debt Conversion, Converted Instrument, Shares Issued                                                       34,737,400   34,737,400  
Amortization of Debt Discount (Premium)                                                           $ 0  
Amortization of Debt Issuance Costs                                                       $ 69,418   $ 115,000  
Debt Conversion, Converted Instrument, Amount $ 106,312                                                            
First Tranche [Member] | Convertible Debt 400000 [Member]                                                              
Debt Instrument, Face Amount                                                   100,000          
Proceeds from Convertible Debt                                                   $ 85,000          
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
DERIVATIVE LIABILITIES (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2018
Sep. 30, 2018
Sep. 30, 2018
Derivative Liability   $ 3,205,183 $ 3,205,183
Derivative, Gain (Loss) on Derivative, Net     $ 2,671,002
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate     0.00%
Debt Conversion, Converted Instrument, Shares Issued 5,280,000   74,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements     $ (9,336,681)
Revaluation [Member]      
Derivative Liability   6,818,117 6,818,117
Derivative, Gain (Loss) on Derivative, Net   $ 919,147 $ 11,640,425
Share Price   $ 0.0234 $ 0.0234
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate     0.00%
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements     $ 9,336,681
Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price   0.0009 $ 0.0009
Share Price   0.0029 $ 0.0029
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     86.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     2.03%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     1 year
Minimum [Member] | Revaluation [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price   0.0008 $ 0.0008
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     95.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     2.63%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     6 months
Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price   0.0137 $ 0.0137
Share Price   0.0550 $ 0.0550
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     214.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     2.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     5 years
Maximum [Member] | Revaluation [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price   $ 0.0880 $ 0.0880
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     214.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     2.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     4 years 10 months 24 days
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
WARRANTS (Details)
9 Months Ended
Sep. 30, 2018
$ / shares
Annual dividend yield 0.00%
Maximum [Member]  
Expected life (years) 5 years
Risk-free interest rate 2.80%
Expected volatility 214.00%
Common stock price $ 0.0550
Minimum [Member]  
Expected life (years) 1 year
Risk-free interest rate 2.03%
Expected volatility 86.00%
Common stock price $ 0.0029
Employee Stock Option [Member]  
Annual dividend yield 0.00%
Risk-free interest rate 2.63%
Expected volatility 91.00%
Common stock price $ 0.0234
Employee Stock Option [Member] | Maximum [Member]  
Expected life (years) 4 years 10 months 24 days
Employee Stock Option [Member] | Minimum [Member]  
Expected life (years) 3 years 9 months 18 days
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
WARRANTS (Details 1)
9 Months Ended
Sep. 30, 2018
$ / shares
shares
Class of Warrant or Right [Line Items]  
Outstanding at beginning 23,426,087
Issuances 69,919,777
Exercises (223,803,769)
Anti-Dilution/Modification 401,430,751
Forfeitures/cancellations (15,200,000)
Outstanding at Ending 255,772,846
Weighted Average Price at September 30, 2018 | $ / shares $ 0.0023
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUBSEQUENT EVENTS (Details Textual) - USD ($)
1 Months Ended
Nov. 12, 2018
Oct. 22, 2018
Oct. 18, 2018
Jul. 16, 2018
Subsequent Event [Line Items]        
Debt Instrument, Convertible, Beneficial Conversion Feature       $ 114,000
Subsequent Event [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Conversion of Stock, Amount Issued   $ 11,967,158    
Debt Instrument, Convertible, Beneficial Conversion Feature   $ 115,000    
Stock Issued During Period, Shares, New Issues 25,055,575   9,297,576  
Warrants Exercised 28,200,000   10,000,000  
EXCEL 39 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 41 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 254 172 1 false 67 0 false 4 false false R1.htm 1001 - Document - Document And Entity Information Sheet http://www.Jolleymarketing.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.Jolleymarketing.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.Jolleymarketing.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Sheet http://www.Jolleymarketing.com/role/CondensedConsolidatedStatementOfOperations CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Statements 4 false false R5.htm 1005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Parenthetical) Sheet http://www.Jolleymarketing.com/role/CondensedConsolidatedStatementOfOperationsParenthetical CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 1006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.Jolleymarketing.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 1007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.Jolleymarketing.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 1008 - Disclosure - LICENSING AGREEMENTS Sheet http://www.Jolleymarketing.com/role/LicensingAgreements LICENSING AGREEMENTS Notes 8 false false R9.htm 1009 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.Jolleymarketing.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 9 false false R10.htm 1010 - Disclosure - DEBT Sheet http://www.Jolleymarketing.com/role/Debt DEBT Notes 10 false false R11.htm 1011 - Disclosure - DERIVATIVE LIABILITIES Sheet http://www.Jolleymarketing.com/role/DerivativeLiabilities DERIVATIVE LIABILITIES Notes 11 false false R12.htm 1012 - Disclosure - WARRANTS Sheet http://www.Jolleymarketing.com/role/Warrants WARRANTS Notes 12 false false R13.htm 1013 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.Jolleymarketing.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 13 false false R14.htm 1014 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.Jolleymarketing.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 14 false false R15.htm 1015 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.Jolleymarketing.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.Jolleymarketing.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies 15 false false R16.htm 1016 - Disclosure - DEBT (Tables) Sheet http://www.Jolleymarketing.com/role/DebtTables DEBT (Tables) Tables http://www.Jolleymarketing.com/role/Debt 16 false false R17.htm 1017 - Disclosure - WARRANTS (Tables) Sheet http://www.Jolleymarketing.com/role/WarrantsTables WARRANTS (Tables) Tables http://www.Jolleymarketing.com/role/Warrants 17 false false R18.htm 1018 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.Jolleymarketing.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.Jolleymarketing.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables 18 false false R19.htm 1019 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) Sheet http://www.Jolleymarketing.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsTextual ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) Details http://www.Jolleymarketing.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables 19 false false R20.htm 1020 - Disclosure - LICENSING AGREEMENTS (Details Textual) Sheet http://www.Jolleymarketing.com/role/LicensingAgreementsDetailsTextual LICENSING AGREEMENTS (Details Textual) Details http://www.Jolleymarketing.com/role/LicensingAgreements 20 false false R21.htm 1021 - Disclosure - RELATED PARTY TRANSACTIONS (Details Textual) Sheet http://www.Jolleymarketing.com/role/RelatedPartyTransactionsDetailsTextual RELATED PARTY TRANSACTIONS (Details Textual) Details http://www.Jolleymarketing.com/role/RelatedPartyTransactions 21 false false R22.htm 1022 - Disclosure - DEBT (Details) Sheet http://www.Jolleymarketing.com/role/DebtDetails DEBT (Details) Details http://www.Jolleymarketing.com/role/DebtTables 22 false false R23.htm 1023 - Disclosure - DEBT (Details Textual) Sheet http://www.Jolleymarketing.com/role/DebtDetailsTextual DEBT (Details Textual) Details http://www.Jolleymarketing.com/role/DebtTables 23 false false R24.htm 1024 - Disclosure - DERIVATIVE LIABILITIES (Details Textual) Sheet http://www.Jolleymarketing.com/role/DerivativeLiabilitiesDetailsTextual DERIVATIVE LIABILITIES (Details Textual) Details http://www.Jolleymarketing.com/role/DerivativeLiabilities 24 false false R25.htm 1025 - Disclosure - WARRANTS (Details) Sheet http://www.Jolleymarketing.com/role/WarrantsDetails WARRANTS (Details) Details http://www.Jolleymarketing.com/role/WarrantsTables 25 false false R26.htm 1026 - Disclosure - WARRANTS (Details 1) Sheet http://www.Jolleymarketing.com/role/WarrantsDetails1 WARRANTS (Details 1) Details http://www.Jolleymarketing.com/role/WarrantsTables 26 false false R27.htm 1027 - Disclosure - SUBSEQUENT EVENTS (Details Textual) Sheet http://www.Jolleymarketing.com/role/SubsequentEventsDetailsTextual SUBSEQUENT EVENTS (Details Textual) Details http://www.Jolleymarketing.com/role/SubsequentEvents 27 false false All Reports Book All Reports celz-20180930.xml celz-20180930.xsd celz-20180930_cal.xml celz-20180930_def.xml celz-20180930_lab.xml celz-20180930_pre.xml http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 45 0001144204-18-059990-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-18-059990-xbrl.zip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end